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ABSTRACT
Research documents that breast cancer is the leading cause of death in Latina females.
The exact numbers are unknown, but studies reveal that Latinas with breast cancer
underuse recommended follow-up chemotherapy, decreasing their rates of survival.
Although several factors may be responsible, cultural influences are a possible barrier.
However, there is a gap in the literature about how culture affects decisions about breast
cancer treatment. This focused ethnographic study examined the role of cultural beliefs
and perceptions in the decision-making process for Latina women about whether or not to
receive chemotherapy following a breast cancer diagnosis. Drawing from Douglas’
cultural theory of risk, archived in-depth interview data from 20 Latina breast cancer
survivors were open coded into 56 primary codes which were then categorized into
hierarchical trees of overarching themes and subcategories. Unique elements of the
patterns observed in these data were analyzed and interpreted to explain how culture may
influence Latina breast cancer patients to underuse recommended chemotherapy. The
results of this qualitative analysis revealed that various cultural factors including social
role-related themes, avoidance of information and communication, as well as
employment and immigration status influenced the treatment decisions of Latina women.
Analysis suggested that these cultural factors influenced both the amount and quality of
information Latina women had available to make these decisions. Results of this study
can accelerate social change by drawing increased attention to cultural differences in
medical decision making and by informing the communication process between medical
providers and their Latina patients.
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CHAPTER 1: INTRODUCTION TO THE STUDY
Statement of the Problem
Latinos are the fastest growing minority group in the United States, and by 2050,
25% of the U.S. population will be Latino (U.S. Census Bureau, 2000). Breast cancer is
the most common cancer among U.S. Latino females, also referred to as Latinas. For this
study, the term Latino is used to generalize to all persons self-identified as Latino or
Hispanic, including those from Latin America and the islands of the Caribbean. The term
will be used to refer to Latinos in Latin countries and the United States. Chapter 2
contains a more detailed discussion of the demographics of Latinos in the United States
and in the greater Washington, DC, area.
U.S. Latinas are at greater risk than non-Latinas of dying from their breast cancers
(Clegg, Li, Hankey, Chu, & Edwards, 2002). Some of the difference in death risk may be
attributed to late stage at presentation (Abraido-Lanza et al., 2007; Boyer-Chammard,
Taylor, & Anton-Culver, 1999; Clegg et al.). To date, attempts to reduce survival
disparities have focused on early detection. However, even after considering the stage of
diagnosis, Latinas continue to have poorer survival rates than other groups (Bickell et al.,
2006; Katz et al., 2005). Some deaths may be attributed to the underuse of optimal
treatments such as chemotherapy and radiation, especially adjuvant chemotherapy
(National Institute of Medicine, 2002). A recent study of females who did not receive the
recommended adjuvant chemotherapy for their breast cancer found that among Latinas,
23% refused; 52% were considered system failures, that is, no reason was given for their
failure to receive treatment; and 25% were not offered treatment by their surgeons
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(Bickell, LePar, Wang, & Leventhal, 2007). There are many possible explanations for
suboptimal treatment patterns in Latinas, including access barriers, language problems,
low health literacy, and bias in the health care system (Geiger & Borchelt, 2003; Guidry,
Fagan, & Walker, 1998). However, there is evidence that cultural factors, including
perceptions of illness, disease, and cure, as well as other cultural norms and values, may
be very important factors in determining the uptake of chemotherapy (Bickell et al.,
2006). The research problem in this study addressed Latinas’ failure to obtain
recommended treatment following surgery for breast cancer.
Need for Research
Although other studies have shown cultural differences in perceptions about
cancer and cancer screening (Borrayo & Jenkins, 2003; Perez-Stable, Sabogal, OteroSabogal, Hiatt, & McPhee, 1992), little is known about the cultural norms that affect
decisions by Latinos to use chemotherapy. Latino cultures share a philosophy of health
that is different from those in the United States (Perez-Stable et al.). For example, illness
is viewed as holistic and concerned with the experience of symptoms; in addition, the
effects of treatment are perceived as part of the illness (Kleinman, 1995). This must be
understood as a basis for interpreting the rationale for health behavior (Kleinman).With a
thorough understanding of Latino culture concerning illness and disease, one may begin
to explore how patients make sense of disease and illness, relate to their providers, and
make decisions regarding the use of recommended therapies.
Although there have been few studies of treatment for cancer in Latinos, some
research has indicated areas of interest to be explored. First, Latinos fear cancer more
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than any other disease, but they do not believe that early detection is useful (EhrmannFeldmann, Spitzer, Del Greco, & Desmeules, 1987; Flanagan & Holmes, 2000; Manson,
Manderino, & Johnson, 1993; Sontag, 1983). Latinas have been found to be less
convinced than Whites or Blacks that adjuvant cancer treatment is effective (Chavez,
Duran, Baker, Avila, & Wallerstein, 2003). Second, Latinos have been identified as being
more fatalistic than other groups, and these beliefs have been associated with low cancer
screening use (Chavez et al.; Facione & Giancarlo, 1998; Hubbell, Chavez, Mishra,
Magana, & Valdez, 1995; Perez-Stable, Otero-Sabogal, Sabogal, McPhee, & Hiatt,
1994). Third, cultural norms such as an emphasis on the collective good or needs of the
family may lead women to defer their own care (Chang et al., 1996) and may impede
their use of chemotherapy (Modiano, Villar-Werstler, Meister, & Figueroa-Valles, 1995).
Chang et al. found that even when screening has occurred, Latinas have a longer interval
between abnormal mammography and diagnostic testing. Fourth, shame and secrecy
about cancer may lead the family to withhold information from the patient, precluding
informed treatment decisions. In Latino cultures, there is a tendency for the physician and
the family to withhold information about cancer from the patient, including prevention,
screening, and prognosis (Marin & Marin, 1991). Researchers have found that shame and
secrecy about cancer foster mistaken beliefs (Campaña, 1989; Marin & Marin; PerezStable et al., 1992).
Evidence from other studies on the beliefs about cancer risks and screening
among Latinas has suggested that perceptions and beliefs play a significant role in health
behavior. These studies have shown the differences in knowledge and attitudes about
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breast cancer risk factors among Latinas and White females (Chavez et al., 2003; Facione
& Giancarlo, 1998; Hubbell, Chavez, Mishra, & Valdez, 1996). Other studies have
highlighted the role of religion; social support, distress, and life disruption; and
psychosocial well-being among Latina cancer patients (Alferi, Carver, Antoni, Weiss, &
Duran, 2001; Mickley & Soeken, 1993; Spencer et al., 1999). These studies have
highlighted the need to understand the culture that underlies these values and norms in
medical care. The gap in knowledge is how Latino culture may influence the use of
recommended chemotherapy for breast cancer.
Breast Cancer
According to the National Cancer Institute (NCI, 2007), breast cancer is a disease
in which malignant (i.e., cancerous) cells form in the tissues of the breast. It is important
to understand staging because optimal treatment depends on the type and stage of the
cancer, hormone receptivity, and other factors such as comorbidity. After breast cancer
has been diagnosed, the staging process is done to find out if the cancer cells have spread
within the breast or to other parts of the body. Following are the stages of breast cancer
listed on the NCI’s Web site:
1.

Stage 0: Carcinoma in situ.

2.

Stage I: The tumor is 2 centimeters or smaller and has not spread outside
the breast.

3.

Stage IIA: No tumor is found in the breast, but cancer is found in the
axillary lymph nodes (i.e., the lymph nodes under the arm); the tumor is 2
centimeters or smaller and has spread to the axillary lymph nodes; or the
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tumor is larger than 2 centimeters, but not larger than 5 centimeters, and
has not spread to the axillary lymph nodes.
4.

Stage IIB: The tumor is either larger than 2 centimeters, but not larger than
5 centimeters, and has spread to the axillary lymph nodes, or it is larger
than 5 centimeters, but has not spread to the axillary lymph nodes.

5.

Stage IIIA: No tumor is found in the breast, but cancer is found in the
axillary lymph nodes that are attached to each other or to other structures;
the tumor is 5 centimeters or smaller and has spread to the axillary lymph
nodes that are attached to each other or to other structures; or the tumor is
larger than 5 centimeters and has spread to the axillary lymph nodes that
may be attached to each other or to other structures.

6.

Stage IIIB: The cancer may be any size and has spread to tissues near the
breast (e.g., the skin or chest wall, including the ribs and muscles in the
chest), and it may have spread to lymph nodes within the breast or under
the arm;

7.

Operable Stage IIIC: The cancer has spread to lymph nodes beneath the
collarbone and near the neck, and it may have spread to lymph nodes
within the breast or under the arm and to tissues near the breast.

8.

Inoperable Stage IIIC. The cancer is found in 10 or more of the lymph
nodes under the arm, in the lymph nodes beneath the collarbone and near
the neck on the same side of the body as the breast with cancer, or in
lymph nodes within the breast itself and in lymph nodes under the arm. In
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Inoperable Stage IIIC breast cancer, the cancer has spread to the lymph
nodes above the collarbone and near the neck on the same side of the body
as the breast with cancer.
9.

Stage IV: The cancer has spread to other organs of the body, most often
the bones, lungs, liver, or brain.

Treatment of Breast Cancer
According to the NCI (2007) treatment guidelines, recommended treatments for
Stage I, Stage II, Stage IIIA, and Operable Stage IIIC breast cancer include surgery,
either mastectomy or breast-conserving surgery, and adjuvant therapy, that is, treatment
given after surgery to increase the chances of a cure. Adjuvant treatments include
radiation therapy to the lymph nodes near the breast and the chest wall after a modified
radical mastectomy; systemic chemotherapy with, or without, hormone therapy; hormone
therapy; or a clinical trial of trastuzumab (Herceptin), combined with systemic
chemotherapy. These recommendations were important for this study because the
researcher sought to recruit women who would have been candidates for chemotherapy
based on their disease. Staging has been used by other researchers to identify the use and
underuse of chemotherapy in large populations where medical records are available.
Because this researcher did not have access to medical records, participant recruitment
was based on Stage 1 or higher among females who had had surgery for breast cancer.
Breast Cancer in Latinas
Despite the fact that Latinas in the United States have a 30% lower incidence of
breast cancer than White females, breast cancer is the most frequently diagnosed cancer
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and the leading cancer cause of death in Latinas (American Cancer Society, 2007). With
the growth in the Latino population, the number of Latinas at risk for breast cancer will
increase dramatically over the coming decades. This group is underrepresented in breast
cancer prevention and treatment trials (Marin & Marin, 1991). Studies have found that
Latinas have the lowest regular mammography screening rates of any group in the United
States (Gilliand, Rosenberg, Hunt, Stauber, & Key, 2000; “Healthy People 2010,” 2004;
Perez-Stable, Hiatt, Sabogal, & Otero-Sabogal, 1995). Ell et al. (2002) concluded that
Latinas need support for diagnostic follow-up because they are less likely to follow up
abnormal mammograms.
Multiple clinical trials have demonstrated the survival benefits of systemic
therapy, which is considered part of the standard of care for most invasive breast cancers
(Goldhirsch, Colleoni, Domenighetti, & Gelber, 2003; Safran et al., 1998). However,
studies have shown that Latinas have fewer consultations with medical oncologists,
receive less aggressive chemotherapy regimens, and are more likely to discontinue
chemotherapy than White females. They also are less likely than White females to have
endocrine therapy prescribed (Bickell et al., 2006; Haggstrom, Quale, & Smith-Bindman,
2005; Polacek, Ramos, & Ferrer, 2007).
Studies have shown that when Latinas receive definitive treatment, their survival
outcomes are similar to those for non-Latina White females (Bickell et al., 2006; Elledge,
Clark, Chamness, & Osborne, 1994; Katz et al., 2005). However, there has been recent
interest in the possible biologic/genetic basis of differences between Latino and nonLatino women at diagnosis. Watlington, Byers, Mouchawar, Sauaia, and Ellis (2007)
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found that despite equal use of health care services such as mammography, Latinas
diagnosed with breast cancer are different from non-Latino women in size, stage, and
grade of tumor. Biologic/Genetic differences make it even more important that Latino
women have the recommended treatment when diagnosed.
There are many possible explanations for the underuse of chemotherapy among
Latinas. These include a lack of insurance, low education, and low income. Studies of
chemotherapy use in other cancers (McGory, Zingmond, Sekeris, Bastani, & Ko, 2006;
Naeim, Hurria, Leek, & Maly, 2006; Zell, Rhee, Ziogas, Lipkin, & Anton-Culver, 2007)
have concluded that socioeconomic status (SES) may be a more important predictor of
appropriate care than race or ethnicity. However, a recent landmark study by Bickell et
al. (2006) examined the differences among White, Black, and Latino females who had
had surgery for Stage I or Stage II breast cancer. Of these, the minority females had
double the risk of receiving inappropriate, or no, adjuvant therapy. All the females in this
study had access to care. Considering other factors such as comorbidities, the researcher
concluded that many of the reasons for underuse in minority females remain unknown.
The psychological and cultural barriers involving communication between patients and
physicians must be understood for changes to take place.
Demographic Profile of Latinos
Latinos are the fastest growing minority population in the United States. By 2000,
there were approximately 36 million Latinos living in the United States, representing
13% of the total population (U.S. Census Bureau, 2000). Based on census data,
researchers have estimated that the actual population from this ethnic group is
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undercounted by as much as 30% to 50% (Capps & Passel, 2003; Grieco, 2003; Singer,
Friedman, Cheung, & Price, 2001). The U.S. Census Bureau predicted that by 2050, 25%
of the U.S. population will be Latino, making this the single largest minority group in the
country. The greater Washington, DC-Baltimore region has one of the largest urban
concentrations of Latinos in the country, and persons of this ethnicity are largely
clustered in contiguous tristate counties (i.e., District of Columbia, Maryland, Virginia).
The populations of these urban communities are predominately of Central (and South)
American ancestry, with the greatest numbers from El Salvador (Capps & Passel; Grieco;
Singer et al.).
These groups also are distinct in that 52% to 64% have recently immigrated to the
United States, compared to an average of 29% nationally; often lack legal residence
status; are poorly educated (21% have less than a Grade 9 education); and are
predominately monolingual in Spanish. A total of 32% to 46% are estimated to be
uninsured, and at least 20% are living in poverty, a rate that is twice the national average
(Capps & Passel, 2003; Grieco, 2003; Singer et al., 2001). At present, there are limited
data on the health status cancer care needs of this understudied Latino subgroup.
Cancer Disparities in Latinos
The cancer burden among U.S. Latinos is difficult to evaluate for a variety of
reasons. The Surveillance, Epidemiology, and End Results (SEER) Program, established
in 1973 as part of the NCI (2007), collects cancer incidence, treatment, and survival data
to monitor the burden of cancer on the population of the United States. By virtue of the
location of the original SEER registries, until recently, the majority of cancer data has
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focused on Latinos of Mexican decent (O’Brien et al., 2003). With the expansion of the
Centers for Disease Control and Prevention’s state-based registry initiative, data on
additional Latino groups are now being included in cancer statistics and census
categorizations (as cited in O’Brien et al.; Ries, Kosary, Hankey, & Edwards, 1999).
However, efforts to identify persons of different Latino ancestry are in their infancy, and
the reliability and validity of current methods are variable in application (North American
Association of Central Cancer Registries, 2003). In addition, although cancer rate
denominators are based on census counts of participating self-identified Latinos,
numerators are often based on nonstandard medical record reports of ethnicity to cancer
registries, possibly leading to biased estimates of cancer rates (Stewart, Swallen, Glaser,
Horn-Ross, & West, 1998). Finally, population surveys often do not include sufficient
numbers of Latinos to identify stable rates of health behaviors, especially within Latino
subgroups (Stewart et al.).
Based on current data, it appears that Latinos have higher than average rates of
cancers that are related to infectious agents (e.g., cervical, stomach, and liver cancer;
O’Brien et al., 2003; Ries et al., 1999). For other cancer sites (e.g., breast and colorectal
cancer), U.S. Latinos seem to have lower incidence rates than average (O’Brien et al.),
but if they do develop cancer, they are more likely than Whites to be diagnosed at late
stages of the disease and are more likely to die of the disease (Hedeen & White, 2001;
O’Brien et al.; Richardson et al., 1992). This disproportionate burden of cancer death and
illness may be the result of multiple predisposing, reinforcing, or enabling factors
operating at the individual and community levels, such as low use of screening rates;
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erosion of access to services; and/or difficulty obtaining timely, high-quality, culturally
competent cancer care. With increases in obesity and other lifestyle changes associated
with immigration and acculturation, Latinos in the United States also may become
increasingly at risk for common cancers. Moreover, with the dramatic growth of the
Latino population, even if lower incidence rates persist, the absolute numbers of
individuals at risk for cancer will increase over the coming decades. Thus, Latinos have a
significant and disproportionate burden of cancer death and illness, and some of this
burden is attributable to treatment that is less than optimal. Although many factors
influence treatment use, there is evidence that beliefs, perceptions, and cultural norms are
important to individual patient decisions. At present, little is known about these culturally
based attitudes that may affect Latinas’ decisions to use chemotherapy.
Nature and Purpose of the Study
Because of the researcher’s employment and involvement in the Latin American
Cancer Research Coalition (LACRC), she, along with two colleagues, gathered a large
amount of qualitative data from Latina breast cancer survivors. The archived data,
gathered in 2004, included more than 400 hours of interview transcriptions. The objective
of this study was to analyze these data, which had not been systematically analyzed
previously. The focus of the analysis was to explore these narratives to identify cultural
beliefs, values, and norms that may explain Latinas’ decisions to use, or not use,
recommended adjuvant therapy for breast cancer. The purpose of the study was to
provide a deeper understanding of the cultural barriers to treatment, which if addressed,
may assist efforts to improve decision making and eventually decrease mortality from
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cancer among Latinas.
Theoretical Framework
The theoretical basis of this study was cultural theory and the cultural theory of
risk. Arising from anthropology, cultural theory posits that beliefs and values are shared
among participants, beliefs and values are learned, and behavior is patterned (Helman,
2007; Kleinman, 1995; Morse & Field, 1995). Further, the study was based on the
medical anthropological theory of Kleinman that disease is not an entity, but an
explanatory model. He argued that disease belongs to culture and to the specialized
culture of medicine. It follows that to understand the behavior of a culture, one must
understand how disease and treatment are perceived by those in the culture.
The cultural theory of risk arises from cultural anthropology. It posits that the
perception of risks arises from each society’s attempts to explain misfortune (Douglas,
1997). Ethnography is the primary tool of anthropological research (Creswell, 1998;
Patton, 1990; Woolcott, 1994). Focused ethnography, or particularistic ethnography, is a
limited ethnography that focuses on a single problem within a small group and which has
been used increasingly in medicine, especially in nursing research (Morse & Field, 1995).
Like ethnography, which focuses on the question, “What is the culture of this group of
people?” (Patton, p. 67), focused ethnography asks the question, “What is going on in this
group about this issue or problem?” This method uses the steps of (a) comprehension of
the individual’s experiences, (b) synthesis of categories within narratives,
(c) identification of cultural norms in the data, (d) theorizing by comparing beliefs and
values in the data with those in the literature, and (e) retextualizing by comparison with
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existing theory. Focused ethnography results in description, analysis, and interpretation
of cultural themes, but it does not result in model development and in substantive theory
(Wolcott). Rather, it results in an interpretation of cultural themes. This interpretation
may be compared and contrasted to existing theory.
The researcher chose a qualitative research design because it was well suited to a
study in which not enough was known about the topic to frame clear questions and where
the issues were complex, sensitive, and difficult to access. Although cultural issues may
be examined by using a general population of Latinas, there is evidence that females who
have been newly diagnosed with breast cancer change their views and perceptions. For
these reasons, the researcher chose to analyze the interview data provided by 20 newly
diagnosed patients. As discussed in detail in chapter 3, the selected method was focused
ethnography using in-depth interviews. The product of this study was a descriptive theory
that may be used to improve practice and, ultimately, to save lives.
Study Design and Collection of the Archived Data
The following is a description of the methods used to collect the archived data.
Newly diagnosed, foreign-born, Spanish-speaking Latina breast cancer patients (i.e.,
diagnosed within the last year with local and regional breast cancer) were identified by
three physicians: a surgeon in Washington, DC; an oncologist in Montgomery County,
MD; and an oncologist in Arlington, VA. These physicians were selected by the
researcher as those to whom Spanish community clinics refer and who see the most
Spanish-speaking patients. They identified the patients and allowed LACRC staff to
introduce the study and obtain consent. The females were interviewed in their homes by a
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team that included at least one bilingual, bicultural interviewer. This was a purposive,
convenience sample of women who were diagnosed in the past year, who were referred
to LACRC, and who agreed to participate. The goal was to interview 20 women, a
number suggested by Morse and Field (1995) as adequate for a qualitative study. Most
interviews were conducted in Spanish and were recorded with the participants’
permission. The open-ended, unstructured question protocol was designed to encourage
candid narration about the cancer treatment experience. Probes were added to be used if a
topic was not mentioned (see Appendix A). Interviews ranged from 2 to 3 hours. Audio
tapes were transcribed and back translated into English.
Specific Research Questions, Hypotheses, or Objectives
The overarching research question in this study asked, “What are the cultural
beliefs, values, and norms that influence Latinas in choosing to have recommended
chemotherapy?” Although this culture also shares language and practices, the researcher
believed that beliefs, values, and norms were the most likely to affect health behavior
relevant to this inquiry. As mentioned previously, little is known about how shared
beliefs, values, and cultural norms may influence health behavior in this population.
Because it is generally accepted that culture and acculturation affect general health care
beliefs and utilization, a study of the beliefs and perceptions about chemotherapy in a
diverse Latino population should identify important targets for future interventions aimed
at improving outcomes for this understudied population.
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Definitions of Terms
Breast Cancer: Defined by the NCI (2007) as a disease in which malignant (i.e.,
cancerous) cells form in the tissues of the breast.
Culture: For the purposes of this study, culture is defined as shared systems of
ideas, concepts, rules, and meanings that influence how persons live life and make sense
of events (Helman, 2007).
Latino/Latina: These terms are used to denote individuals living in the United
States who were born or who can trace their ancestry to one of the Latin American
countries, including islands of the Caribbean, and who speak Spanish or Portuguese. This
is a cultural categorization, not a racial one. Although Latinos in the United States are
heterogeneous, with disparate migrational and socioeconomic characteristics, the
researcher assumed that members of this group share some common basic cultural values
that make them members of an identifiable group. In addition, the sample of Latinas
studied here was more homogeneous demographically than the U.S. population of
Latinos.
Recommended Chemotherapy: A term that refers to NCI guidelines for practice.
All of the female participants in this study had stages of cancer where chemotherapy
would have been recommended. For instance, Stage O would not indicate treatment with
chemotherapy, but Stage 2 would most always indicate chemotherapy (NCI, 2007).
Limitations of the Study
The sample size of a qualitative study is not meant to predict to a larger
population. The goal to interview 20 women was selected a priori to answer the research
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question and to ensure saturation with the topic. Likewise, it cannot compare groups,
such as groups of more or fewer acculturated patients, or nationalities, both of which may
be relevant to the study and should be investigated in the future. This sample, mostly
low-income, unilingual, new immigrants from Central America, was not expected to
reflect the range of experiences of U.S. Latinas. However, this sample did reflect the
demographics of Latinos in the Washington, DC, area. In addition, most of the women
were recruited from two oncologists, further limiting the heterogeneity. Because of the
homogeneity of the sample, the lower end of the recommended number of 20 was chosen
to be feasible within the scope and timeframe of the study (Lincoln & Guba, 1985;
Morse, 1994). As explained by Morse, “Comprehension is complete when the researcher
has conducted enough participant interviews to describe the events, incidents, and
exceptions form an emic perspective” (p. 37). This level of comprehension was achieved
with the planned 20 interviews. If additional interviews had been needed for saturation,
the data collection would have continued.
A qualitative study relies on volunteers and does not attempt a representative
sample. Because some of the females were recruited from two oncologists referred from
the LACRC, they may have been more acculturated than females who do not visit an
oncologist. However, because all of the referring physicians were Spanish-speaking
specialists who see most clinic patients, their patients may have been less likely to speak
English. An examination of cultural beliefs and perceptions of non-English-speaking
(less acculturated) females was expected to provide the richest material because less
acculturated woman are more likely to retain their cultural values.
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Another limitation was working with two languages. However, bilingual and
bicultural interviewers were present for or conducted all of the archived interviews. Body
language and other subtleties can be lost using transcriptions, but both interviewers took
notes during the interviews, and these notes were added to the data in the software. Five
percent to 10% of each audio tape and transcript was reviewed by a second Spanish
speaker.
Scope of the Study
This study examined the cultural reasons, that is, the beliefs, values, and norms,
which may have influenced 20 Latinas to choose, or not choose, adjuvant treatment,
especially chemotherapy, following a diagnosis of breast cancer. It is understood that
there may have been many factors not directly related to culture, such as access to care,
and that these factors may also have been influential. Moreover, these factors may have
been difficult to separate from cultural differences in a population with low education,
poverty, and language differences. Because the sample was demographically homogeneous, these questions were not
answered by this study. Instead, the

researcher attempted to focus on cultural factors. Finally, this

study was not designed to identify females who had refused chemotherapy and to learn
the reasons for their decisions because (a) the researcher did not have data on specific
diagnosis or recommendations, and (b) the purpose of the study was to identify overall
cultural influences.
Significance of the Study
This study was the first study that that this researcher knows of its kind with this
population. It may lead to interventions to change beliefs and perceptions of adjuvant
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therapy, especially chemotherapy, following breast cancer. The results may be used by
clinicians in their practices to improve their communication with Latina patients and by
other groups to provide educational and counseling interventions. These results also may
inform researchers about cultural influences on the decision to accept chemotherapy as a
treatment for other cancers, especially other female cancers. The findings also may be
used by other researchers to explore health behaviors for other diseases.
Disparities in cancer mortality are a public health concern. A woman of color in
the District of Columbia is twice as likely as a White female to die of breast cancer.
Efforts to reach the Latino community have too often involved simply translating English
materials into Spanish without understanding how Latino cultures make sense of illness
and treatment, the literacy level of the audience, and other barriers. Health
communication efforts will not be successful without a deeper understanding of the target
audience. Positive social change is necessary to reduce cancer mortality among Latinas.
Social Change
Many changes will need to be made to impact the growing disparities in breast
cancer mortality in minority women in this country. As discussed in chapter 2, different
cultures require different interventions to improve care. Basic to the development of new
interventions is a fuller understanding of each culture’s values, beliefs, and norms
regarding disease, illness, care, and treatment. This study may provide information about
relevant cultural factors among a group of Latinas with breast cancer to inform
interventions to improve practice. Only with this understanding can changes be made to
reduce the number of minority women dying from breast cancer.
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Summary
The following chapters outline the study. Chapter 2 presents an overview of the
relevant literature on cancer in Latinas, Latino culture and illness, Latino cultural norms
and values, the theoretical basis of the research, and qualitative research methods.
Chapter 3 describes the methods used in the study, including the primary and secondary
research questions and the data collection and analysis methods that were used to answer
them. Chapter 4 presents results of the analysis and answers to the research questions
arising from the interviews. Chapter 5 is a discussion of the interpretation of results, role
of the researcher, social significance of the study, and recommendations for change.

CHAPTER 2: REVIEW OF THE LITERATURE
Introduction
The review of the literature was undertaken to answer the following subquestions
relevant to the primary research question: What are the cultural beliefs, values, and norms
that influence Latinas in choosing to have recommended chemotherapy?
1.

What are the cultural beliefs about disease and illness and about cancer?

2.

What are the cultural values and norms that may play a role in medical
decisions?

In order to ground the study in previous research, the researcher began by
examining the literature in the following areas:
1. The incidence and prevalence of breast cancer among Latinas.
2. Mortality from breast cancer in Latinas.
3. Evidence that Latinas underuse chemotherapy.
4. Which research methods are the most appropriate for this study?
Organization of the Literature Review
This review begins with evidence of the efficacy of chemotherapy for breast
cancer and its underuse by minority women, particularly Latinas. To explain this
underuse, the researcher examined the literature on the underuse of health care in Latinas
and presents findings about the role of SES, language, and other possible barriers to the
use of healthcare services among Latinas. The theoretical basis for the enquiry and the
qualitative tradition underlying the methods is presented next. To narrow the focus to
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cultural factors, the primary topic of this study, the researcher examined the literature on
Latino culture and health. This focus included Latinas’ beliefs, perceptions, and cultural
values regarding disease in general and cancer and cancer treatment in particular. The
review concludes with a summary of possible interventions and social change activities to
improve mortality statistics for Latinas with breast cancer.
A review of what is known about Latino culture and health care is included.
Keyword searches of the literature included culture and Latino and disease,
chemotherapy and Latina, and cancer and Latino in several databases, including
CINAHL, Ovid, and Medline. The next step was to select references from the most
relevant articles and then access those articles and books. When this step was complete,
the researcher cross-referenced citations to ensure that all relevant literature was
included. This literature included theories, methods, and interventions. Textbooks were
used to obtain information about qualitative methods, conceptual models, and qualitative
research traditions.
Breast Cancer Statistics for Latinas
Breast cancer is the leading cause of cancer death among Latinas in the United
States. Latinas also have higher breast cancer mortality than non-Latina White females,
despite lower age-adjusted incidence rates (Abraido-Lanza et al., 2007). Some of this
disparity may be accounted for by lower screening rates (Goel et al., 2003) and
limitations in access to timely care because of SES factors (Selvin & Brett, 2003). This
disparity also may be the result of inadequate access to appropriate treatment after
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diagnosis. After diagnosis, adjuvant systemic therapy is the single treatment modality
with the greatest potential to reduce survival disparities. Thus, many Latina deaths may
be attributable to disparities in access to optimal treatments such as chemotherapy.
Bickell et al. (2006) and Katz et al. (2005) discussed the role of access to medical care in
the underuse of follow-up treatment in Latinas. Multiple clinical trials have identified the
survival benefits of systemic therapy, which is considered part of the standard of care for
most invasive breast cancers. For example, Goldhirsch et al. (2003) presented evidence of
the survival benefit of systemic therapy. However, Latinas have fewer consultations with
medical oncologists, receive less aggressive chemotherapy regimens, are more likely to
discontinue chemotherapy, and are less likely than White females to have endocrine
therapy prescribed.
Bickell et al. (2006), Katz et al. (2005), and Polacek et al. (2007) presented
studies that agreed on the direction and extent of these disparities. Bickell et al. and Katz
et al. concluded that when Latinas receive definitive treatment, their survival outcomes
are similar to those for non-Latina Whites. However, there has been recent interest in the
possible biologic/genetic basis of differences between Latino and non-Latino women at
diagnosis. Watlington et al. (2007) found that despite equal use of healthcare services
such as mammography, Latinas diagnosed with breast cancer are different from nonLatino women in size, stage, and grade of tumor. Biologic/Genetic differences, which
may explain some of the disparities in mortality, make it even more important that
Latinas have the recommended treatment when diagnosed.
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Underuse of Chemotherapy by Latinas
There are many possible explanations for the underuse of chemotherapy by
Latinas, including a lack of insurance, low education, and low income. For instance, Zell
et al. (2007) studied chemotherapy use for pancreatic cancer and concluded that SES is a
more important predictor of appropriate care than race or ethnicity. As noted earlier,
Bickell et al. (2006) tested the hypothesis that underuse of chemotherapy is the result of a
lack of access to care. They found that minority females with equal access to medical
care had double the risk of receiving inappropriate adjuvant therapy, based on established
guidelines and controlling for comorbidities and other factors. This study concluded that
other factors, such as psychological and cultural barriers, must be understood for changes
to take place.
Theoretical Basis for the Inquiry
The theoretical basis for this study was cultural theory and cultural theory of risk
(Douglas, 1997). The theory of culture posited that the views of individuals in the culture
are determined by the culture. Cultural theory assumed that members of a group with a
common outlook will impose order on reality in particular ways and that culture
determines how an individual perceives disease and illness.
The cultural theory of risk (Douglas, 1997) posited that the views of individuals
on matters are shaped by the nature of social groups of which they are a part. Thus,
patterns are set in cultural relationships, namely, the expectations and value systems of
people belonging to the distinctive groups. The theory assumed that members of groups
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with a common outlook are disposed to impose order on reality in particular ways.
Cultural theory explained risk as a social construction that occurs through the processes
of value identification and trust building.
All human activity relies on social construction. Douglas (1997) asserted:
All knowledge and everything we talk about is collectively constructed. Language
is no private invention. Words are a collective product, and so are meanings.
There could not be risks, illnesses, dangers, or any reality, knowledge of which is
not constructed. ..all evidence has to be constructed. (p. 123)
Thus, perceived risks are a product of collective construction. Cultural theory explained
why researchers prefer to study beliefs, values, and norms as they relate to a culture
rather than a collection of individuals. By understanding the underlying values, it is
possible to explain attitudes and preferences in a way that makes sense within the culture.
Douglas developed this theory as a way of, “vindicating the so-called primitives from the
charge of having a different logic or method of thinking” (p. 3). For example, there is
always some explanation for misfortunes that befall individuals with any social group,
and those explanations are consistent. Assigning blame imposes order on random
misfortune. Understanding this logic is key to comprehension of behaviors. In an earlier
study, Douglas and Wildavsky (1983) provided clarification of the cultural theory of risk.
They explained that even though people in developed countries live longer than they did
50 years ago, and even though there are fewer hazards, people feel more at risk. By this
theory, the reason is attributable to the rise of environmentalism and is socially
constructed.
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Kleinman, Eisenberg, and Good (1978) studied clinical issues from an
anthropologic and cross-cultural research perspective. They distinguished between
disease and illness, a differentiation that shed light on cross-cultural differences in
response to medical care. Illness is a patient’s experiences of disvalued changes in states
of being and social function, whereas diseases are abnormalities in the structure and
function of body organs and systems. Modern physicians are concerned with disease,
whereas patients are concerned with illness. Kleinman et al. made the point that there
often is not a one-to-one relationship between disease and illness and that one may exist
without the other. Illness is culturally shaped in the sense that how one perceives
experience and copes with disease is based on explanations of sickness. Indigenous
healers seek to treat illness rather than disease. Cultures that have a history of healers
expect and trust attention to illness. Maduro (1983) also discussed the significance of the
individual’s cultural heritage and experience in that person’s definition of illness and
disease. This distinction is relevant to the current study because chemotherapy has the
effect of curing disease by increasing illness.
Helman (2007) discussed the distinction between concepts of illness and disease.
He provided case histories of illness without disease and disease without illness. In the
discussion of disease without illness, he stated that this is an increasingly common
occurrence because of improved diagnostic technology: Diagnostic abnormalities in the
body are found, but the patient does not feel unwell. He ascribed some patient
noncompliance to this situation.

26
Theory and Latin American Culture
Culture, although complex and multifaceted, is an important influence on health
behavior. Culture is generally viewed as comprised of shared ideas, meanings, and
values; it is socially constructed and learned, not genetically created and transmitted; and
it includes patterns of behavior guided by common ideas, meanings, and values. Ethnicity
has several meanings: collective culture of a minority group within a larger society;
ethnic origin, or place of ancestry; and ethnic identity (Huerta & Macario, 1999). As an
ethnic group, or community, Latinos share core cultural values that differentiate them
from other groups.
Following the work of Kleinman et al. (1978), Chesla, Skaff, Bartz, Mullan, and
Fisher (2002) contrasted Whites (European Americans) with Latinos in their perceptions
of disease. She described personal models of illness understanding based on an
individual’s complex sense of the disease, including the cause, nature, and course of the
disease. These models are experiential, biomedical, and psychosocial. A significantly
larger percentage of the Latinos, compared with Whites, ascribed to an experiential
model, that is, holistic and concerned with the experience of symptoms. Second, the
Latino sample perceived effects of treatment as part of the illness.
Saint-Germain and Longman (1993) conducted a study examining attitudes
toward breast cancer among 409 Latino females over the age of 50 living in Tucson,
Arizona. Some of the findings illustrated the difference between perceptions of illness
and disease. The females defined health and illness by symptoms and also by the ability
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of the person to carry on with his or her daily activities. One participant commented that
if one can still work, one is not ill. The roots of these understandings and perceptions lie
deep within the cultural memory of a tradition of folk healing.
Foster and Anderson (1978) stated that to understand Spanish-American health
beliefs, it is essential to understand the popular medicine of the countries from which
they are derived. They commented, “For example, contemporary Mexican-American folk
medicine makes little sense unless the reader understands its humoral antecedents and
Catholic rituals and belief having to do with supernatural patrons petitions for help and
the fulfillment of vows” (p. 75).
Curanderismo
Curanderismo is a diverse folk healing system of Latin America. Although
practiced less in recent years in urban settings, its existence in cultural memory shapes, “a
coherent world view of healing that has deep historical roots” (Maduro, 1983, p. 1) and
can influence culture bound syndromes in clinical practice of general medicine. Maduro
outlined the philosophical premises present in the worldview of Latino patients.
Curanderismo is a holistic system expected to treat physiological, psychological, and
social maladjustments. Following are its underlying propositions according to Maduro:
1.

Because the mind and body are one, disease can be caused by strong
emotional states; hot and cold substances relate to and balance and
harmony (some medications are thought to be hot).

2.

The patient is an innocent and passive victim.
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3.

Illness may be caused by the separation of body and soul. This can mean
self rather than soul in a secular sense and has relevance to immigration
and acculturation. The curandero will sometimes treat the soul, but not the
body;

4.

The responsibility for cure resides with the entire family.

5.

There is interpenetration of the natural and supernatural worlds.
Treatments may include penance, prayers, and sacrifice.

6.

Sometimes, a sick person needs to be resocialized because the
acculturative stress of American life and weakening traditional values can
cause illness related to loss of the soul. As a treatment method, ties to the
community are reestablished, and the patient accepts a more conservative
Latin American worldview.

7.

The healer is expected to interact openly. The healer is warm, friendly,
and personal, with a connection to the sacred and gift or calling (llamada)
to healing.

Foster and Anderson (1978) described the view of health underlying Latino folk
medicine as an, “equilibrium model” (p. 74). Equilibrium is expressed in the humoral
pathology belief that to be healthy, the body must keep a balance between hot and cold
calides (qualities or elements). Thus, the role of the healer is to restore balance (Foster &
Anderson). As discussed next, various substances used for treatment are believed to have
humoral qualities.

29
It can be argued that more acculturated Latinos in the United States have no
memory of these traditional values. Kay (1978) studied Mexican-Americans in a large
Southwestern city. She found that of 30 Mexican-American females, none was aware of
the hot and cold system of classifications. She found that many health beliefs and
behaviors came directly from humoral assumptions and were identical to those in
communities in Mexico, where humoral distinctions are common knowledge. She
concluded that traditional medicine shapes modern beliefs and behaviors, even when it is
not consciously ascribed to or known.
Problems of Treatment
Helman (2007) stated that “in order for medical treatment to be acceptable to
patients, it must ‘make sense’ in terms of the Explanatory Models” (p. 111). Agreement
between patient and doctor about the method and purpose of treatment is as important as
agreement about the diagnosis. This is important if the treatment involves unpleasant
physical sensations or side effects that may induce, in effect, a form of temporary illness
(Helman). Prescribed medication may not be taken if it is perceived to cause illness or if
the patient does not feel ill, and a medication may also not be taken if relatives or friends
have previously had side effects from it (Helman). Also, people may use medications in
ways that make sense to them. For instance, a medication thought of as a hot drug may
not be used if certain side effects appear, such as a rash, which is thought to be caused by
a hot imbalance (Helman).
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The distinction between illness and disease and adherence to an experiential
model of disease in Latino culture can be traced to the history of curanderismo and its
underlying philosophical premises. These premises also may be used to understand the
cultural norms of fatalism, respeto, and collectivism, all of which may be relevant to
Latinos’ views of cancer and cancer treatment.
Latino Beliefs and Perceptions of Cancer
Certain basic values shared by Latinos have been identified by various researchers
as influential in health behavior. As stated by Marin and Marin (1991), “There is a level
of disagreement among researchers as to the meaning and implication of some of these
values” (p. 11). Following are a few of the characteristics relevant to this study.
Fatalismo
Fatalismo is a Latino cultural norm that has been studied extensively by
healthcare researchers. According to Perez-Stable et al. (1994), fatalism is the belief that
the course of fate cannot be changed and that life’s events are beyond one’s control. They
surveyed a random sample of 844 Latinos and 510 Anglos. They found significant
differences in misperceptions about the causes of cancer, attribution of symptoms
(experiential differences), and fatalistic beliefs. For instance, significantly more Latinos
ascribed to the statements that “having cancer is like getting a death sentence,” “cancer is
God’s punishment,” “there is very little one can do to prevent getting cancer,” “it is
uncomfortable to touch someone with cancer,” and “they would rather not know if they
had incurable cancer” (Perez-Stable et al., p. 3219). These differences were significant
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after considering gender, education, age, SES, and self-perceived health status. In
contrast, Abraido-Lanza et al. (2007) reviewed the literature about fatalism in Latinas
regarding cancer screening. They made the point that fatalism is difficult to measure
reliably and separate from the powerlessness and stress of lower SES and racism.
Respeto
Respeto is a cultural norm that has relevance to health care. Maduro (1983)
commented:
Respeto not only describes power distance, it also implies decency, a common
humanness that requires people to interact with each other on that level first in
spit of age, sex, class and caste differences. Even when there are social status
differences in behavior, one must first establish rapport and respect: in Latino
culture all other social relationships and interactions are dependent on that
foundation. (p. 874)
This is sometimes described as simpatía, the need for smooth interpersonal relationships
in which criticism and confrontation are discouraged. Other core Latino cultural values
include familisma, the significance of the family, and collectivism, the importance of
friends and extended family in helping to solve problems (Perez-Stable et al., 1994). In
an assessment of quality of life by Juarez, Ferrell, and Borneman (1998), Latino cancer
patients reported having their family as the most important for coping. In Latino culture,
when one family member is sick, everyone is expected to help. Arruda, Larson, and
Meleis (1992) found that Latino patients with cancer identified comfort as the most
important value. This included nurturing, security, quality of life, familiar environment,
normalcy, and ánimo (internal spiritual strength). The most significant characteristics of
comfort mentioned were feeling integrated and nurtured.
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Religion also is important to Latinos in the face of illness (Mickley & Soeken,
1993). They attribute healthiness to a gift from God and illness as a test from God,
reflecting a holistic view of health. In addition, much Latin-American curing involves the
concept of a healer with supernatural powers. Rather than assign this role to a curandero
or to home remedies, they identify God as the ultimate healer. Foster and Anderson
(1978) commented:
For many illnesses, Spanish-Americans frequently seek the intervention of saints,
the Virgin, or Christ, lighting candles and praying at their altars. Often vows of
solemn promises are made to “miraculous” images of Christ or the Virgin: if the
request is granted, the petitioner must fulfill his or her part in the bargain. (p. 76)
Complementary medicine is used by Latino females either with other treatment or
by itself. Alferi et al. (2001) investigated factors predicting the use of complementary
therapies in a multiethnic sample of non-Latino White (64%), Latino (26%), and Black
(10%) females with early-stage breast cancer in Florida. Fifty-two percent of the Latino
females reported using complementary medicine, including herbs and psychoreligious
therapies (Alferi et al.).
Secrecy
Another value that influences Latinos’ heath behavior is secrecy about cancer.
Juarez et al. (1998) found that the word cancer is not mentioned in the patient’s presence
and that it is not uncommon to find family members not disclosing a cancer diagnosis to
the patient based on the belief that knowing is in the patient’s best interest. Secrecy also
protects the privacy of the patient and family, although it may have the effect of isolating
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the patient from social activities. The concept of social death is useful for understanding
secrecy.
Anthropologists such as Foster and Anderson (1978), Helman (2007), and
Kleinman (1995) described rituals of health illness and the management of misfortune
that are common to many societies. They described rituals of social death that come
before or after biological death; usually, these are funeral and grief rituals. In some
circumstance; however, social death may happen when individuals are alive physically
but in subtle ways less alive socially in the eyes of wider society and sometimes their
own families (Foster & Anderson). Sometimes, the diagnosis of a serious disease such as
AIDS or cancer can signal social death; in a culture where this is the case, there is
significant motivation to keep the diagnosis a secret (Foster & Anderson).
Time Orientation
Latino cultures tend to be more present oriented than mainstream American
culture, which tends to be more future oriented. For instance, there is less planning and
worry about the future and more importance on the present. This cultural trait may be
relevant for the use of treatments that may be needed in the future but may cause illness
in the present (Marin & Marin, 1991).
Latinas’ Knowledge and Beliefs About Breast Cancer
Studies of Latinas’ use of preventive services for breast cancer have found on
average that Latinas have a lack of knowledge that creates misperceptions about breast
cancer. For instance, Perez-Stable et al. (1992) surveyed 844 Latinos and 510 Anglos in a
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prepaid health plan. The Latinos were significantly more likely to believe that cancer is
caused by sugar substitutes, bruises from being hit, microwave ovens, ingestion of pork
and spicy foods, breastfeeding, and antibiotics. The Latinas were significantly different
from the Whites in these beliefs, even accounting for gender, education, age,
employment, country of residence, and health status.
Although studies such as the one conducted by Facione and Giancarlo (1998)
have identified cultural differences in perceptions about cancer and cancer screening,
little is known about the cultural norms that affect Latinos’ decisions about the use of
chemotherapy. For example, in one study, Latinos were less convinced than Whites or
African-Americans that cancer treatment is effective (Perez-Stable et al., 1992). Latinos
also tend to be more fatalistic than other groups, and these beliefs have been associated
with low cancer screening use (Perez-Stable et al., 1994). Other cultural norms, such as
an emphasis on the collective good or needs of the family, often lead women to defer
their own care and may impede the use of chemotherapy (Modiano et al., 1995). In
addition, secrecy also may lead the family to withhold information from the patient,
precluding informed treatment decisions.
This qualitative study was designed to fill gaps in current knowledge about
cultural beliefs and perceptions that affect chemotherapy use among Latina breast cancer
patients. The results are intended to inform the design of future interventions to improve
breast cancer outcomes in this growing minority population.
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Method
Because very little is know about the influence of culture on Latinas’ choices of
breast cancer treatment, the researcher used the qualitative method of ethnography for an
inductive and formative study. In other words, the researcher expected that description,
interpretation, and hypotheses would emerge from the data rather than being guided by
them (Morse & Field, 1995).
Cultural theory was described by Helman (2007) and others as behavior that is
patterned by shared beliefs and values. Ethnography is the primary tool of anthropology
(Creswell, 1998). Focused ethnography, or particularistic ethnography, is a limited
ethnography that focuses on a single problem within a small group (Morse & Field,
1995). It provides a means of gaining access to the health beliefs and practices of a
culture or subculture in order to understand how disease and treatment are perceived by
those in the culture. Like ethnography, which focuses on the question, “What is the
culture of this group of people?” (Patton, 1990, p. 67), focused ethnography asks, “What
is going on in this group about this issue or problem?” (Morse & Field, p. 26). According
to Morse and Field, it has been used increasingly in medicine as a way to improve
practice. They explained that this method uses the steps of (a) comprehension of the
individual’s experiences, (b) synthesis of categories within narratives, (c) identification of
cultural norms in the data, (d) theorizing by comparing beliefs and values in the data with
those in the literature, and (e) retextualizing by comparison with existing theory. Focused
ethnography results in description, analysis, and interpretation of cultural themes, but it
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does not result in model development and in substantive theory (Wolcott). Rather, it
results in an interpretation of cultural themes. This interpretation may be compared and
contrasted to existing theory.
The researcher chose a qualitative research design because it was especially well
suited to a study in which not enough was known about the topic to frame clear questions
and where the issues were complex, sensitive, and difficult to access. Although cultural
issues may be examined by using a general population of Latinas, there is evidence that
females who have been newly diagnosed with breast cancer change their views and
perceptions. For these reasons, the researcher chose to analyze the interview data
provided by 20 newly diagnosed patients.
Other Methods
Qualitative research is indicated for studies where little is known and where the
questions beginning with “Why” and “How” can be answered. Creswell (1998) identified
five traditions: biography, phenomenology, grounded theory, case study, and
ethnography. Biography is appropriate for the study of an individual. Phenomenology
explores the experience of a phenomenon. Grounded theory is the most appropriate when
the researcher is attempting to develop a theory.
The research question being asked in this study sought to understand how culture
influences behavior. This required collecting data from many persons within the
subculture of Latina breast cancer survivors. A biography of one individual would not be
sufficient because studying the psychological effects of the phenomenon of breast cancer,
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although interesting, would not answer the specific research question. Grounded theory
was not indicated because it is not one of the expressed goals of this study to develop
theory. Therefore, within qualitative research traditions, focused ethnography was chosen
as the method most suited to answer the research question.
Ethnography evolved from cultural anthropology by such researchers as Cassell
(1992), Davis (1992); and Germain (1979). It was incorporated into healthcare research
by nurse anthropologists to study the effects of culture on health care (Davis), institutions
(Germain), or professional organizations as cultural systems. As Morse and Field (1995)
reported, “Ethnography, always informed by the concept of culture, is a generalized
approach to developing concepts and understanding human behavior from an insider’s
point of view” (p. 23). Focused ethnography, which was developed by health scientists, is
more delineated. For instance, a topic is chosen before data collection activities. Focused
ethnographies are used primarily to improve practice (Morse & Field). The data
collection method most often used in focused ethnography is the in-depth interview. This
method allows the researcher to focus on a topic while allowing the respondent to
describe and discuss it in depth. Thus, rich text is generated. As discussed in detail in
chapter 3, the selected data collection method was in-depth interviews. The product of
this study was a descriptive theory that may be used to improve practice and, ultimately,
to save lives.

38
Summary
The literature showed evidence of the efficacy of chemotherapy for breast cancer
and its underuse by minority women, particularly Latinas. To explain this disparity, the
researcher examined the literature for factors that may describe possible barriers to the
use of recommended treatments by Latinas. Based on cultural theory arising from
anthropology, cultural factors were identified as important to Latinas’ beliefs and
perceptions regarding disease in general and cancer treatment in particular. Chapter 3
describes the research method. Chapter 4 contains the results of the analysis described in
chapter 3. Chapter 5 includes an interpretation of the findings and offers
recommendations for practice.

CHAPTER 3: RESEARCH METHOD
Overview of the Research Design
The goal of this study was to examine the beliefs and perceptions of Latina breast
cancer survivors about chemotherapy. Because this enquiry was in an area where there
has been little or no research, it was a formative study, using the tradition of focused
ethnography. This method was designed to collect rich, open-ended data, analyze them,
compare them to existing literature, describe cultural themes, and suggest how they relate
to aspects of behavior. This description may then be used to inform practice. As such, the
researcher did not ask questions that would fit the domains of existing theories or models,
such as the health belief model, because to do so would have limited the exploration.
Rather, the enquiry was based on the theory of culture, that is, that cultural beliefs,
values, and norms influence health behavior.
This study began with qualitative data already collected and archived. Using an
inductive, qualitative method, the researcher analyzed data gathered in 2004 that were
based on interviews with 20 newly diagnosed females. The combined interviews totaled
approximately 40 hours of transcribed and translated data.
Qualitative Research
Qualitative research is indicated for studies where little is known and where the
questions beginning with “Why” and “How” can be answered. Creswell (1998) identified
five traditions: biography, phenomenology, grounded theory, case study, and
ethnography. Focused ethnography was chosen as the method most suited to answer the
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research questions. The data collection method most often used in focused ethnography is
the in-depth interview. This method allows the researcher to focus on a topic while
allowing the respondent to describe and discuss it in depth. This method generates rich
text.
Data Collection
During the data collection effort, the females were identified and recruited by
physicians whose practices include many Latinas. Interviews were conducted at a time
and place convenient for the participants in Spanish or English, according to their
personal preference. The interviews were audio taped, transcribed, and translated into
English if necessary. Focused ethnography was selected because it is appropriate for
describing and interpreting information on a special topic within subcultural groups
(Creswell, 1998; Morse, 1994). Focused ethnography arises from health sciences and is
usually used to improve practice. It is different from classical ethnography because the
topic, rather than emerging from the data collection and analysis, is elected before data
collection commences. Rather than developing theory, it results in description and
interpretation on a specific topic (Morse, 1989; Muecke, 2007).
Ethical Protection
This study was approved by the IRBs of the medical center where the data were
collected and Walden University (IRB approval #07-25-08-0286130). All respondents at
the time of consent were informed of HIPPA-stated patient rights:
1.

The patient’s right to confidentiality.
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2.

The patient’s right to refuse participation.

3.

The patient’s right to discontinue the study at anytime during the study.

4.

The patient’s right to refuse to respond to questions that he or she deems
inappropriate or uncomfortable.

5.

The potential benefits and harmful effects of participating in the study.

6.

The incentives that will be provided for participation in the study.

7.

The design of the study and what will be expected of the patient if he or
she chose to accept participation

Once these rights were discussed with the participants, they were given a written
consent form to review. Any questions that they had were answered prior to their signing
the consent form. The females then had the choice to refuse or accept participation in the
study. If they refused to sign the form, they were thanked for their time and energy. If
they accepted, they were instructed where to sign and date the consent form, and then the
consenter (MD or interviewer) also signed and dated the consent form in the appropriate
area. All patients received a copy of the signed consent form for their personal records.
All information was confidential and was not linked to the participants by name. All data
reports and publications used only grouped, unidentified data.
Context of the Study
This study was conducted as part of the Latin American Cancer Research
Coalition (LACRC), an NCI-funded regional Community Network Program (CNP). The
goal of the LACRC is to use community-based participatory research to promote cancer
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control in Latinos in the metropolitan District of Columbia area (Kreling et al., 2006).
The LACRC includes 6 community clinics, 2 community hospitals, 1 comprehensive
cancer center, a local Spanish language health radio program, and numerous advocacy
organizations (Kreling et al.). The community clinics serve Latinos almost exclusively
and provide primary care regardless of the individuals’ ability to pay (Kreling et al.). The
current study was conducted with the cooperation of the LACRC’s research program. All
study procedures were approved by the IRB of the medical center where the researcher is
employed.
Setting and Sample
Latino females who were within 2 years of their breast cancer diagnosis were
recruited for the original study in 1996. Because the researcher was interested in
identifying beliefs about chemotherapy, inclusion was restricted to females with invasive
cancer. The females were recruited from the CNP clinics, the oncologists and surgeons
who accept referrals from the clinics, and a local Latino-serving cancer support network.
The females were told that their decision to participate would not affect their care at the
clinic or from their providers and that their names and personal information would
remain confidential. All participants provided written informed consent and received $40
for their time. To examine the question, “What are the cultural beliefs, values, or norms
that influence Latinas in choosing to have recommended chemotherapy?” the researcher
used the qualitative method of focused ethnography, which is grounded in the assumption
that, “culture is viewed as a system of knowledge used by human beings to interpret
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experience and generate behavior” (Spradley, 1980, as cited in Morse, 1989, p. 45).
Focused ethnography permits an examination of health-illness beliefs and practices and
the local language used in relation to them (Muecke, 2007).
Collection of Archived Data
The researcher conducted in-depth semistructured interviews. This approach
combined the practical advantages of the structured approach with the open-ended
discourse style of unstructured listening. Data were gathered to identify cultural themes,
that is, “patterns of recurring messages that represent organizing principles in the cultural
system under study” (Morse, 1989, p. 47). The interviews were organized around an
interview guide that consisted of closed introductory material and an open-ended grand
tour question to encourage a narrative followed by specific prompts or probes. The
interview protocol was developed by the ethnographic method of eliciting a narrative
about the topic: “Now, I’d like to ask you to tell us about the time you were diagnosed
with breast cancer. What happened?” Based on the first responses, probes were added
and asked, if necessary.
The researcher and two colleagues conducted in-depth semistructured interviews
of 90 to 120 minutes in length with the Latina breast cancer patients. The interviews took
place in the women’s homes and were conducted by the researcher and two trained
bilingual female interviewers who were members of the LACRC. The interviews were
audio-taped with permission of the participants. Each interview was translated and
transcribed by a transcription service soon after being conducted. The translations were
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reviewed by bilingual staff.
Trustworthiness of the Data
The first step in assuring reliability was in the selection of the sample. A
purposeful or theoretical sample was chosen because of the breast cancer experience of
the participants and their willingness and ability to be interviewed. The sample was
chosen to be representative of the knowledge domain, not demographic characteristics.
For this reason, it was not expected to be generalizable in the usual sense. However, the
sample was relatively homogeneous, made up of a large percentage of low-income, loweducation, new immigrants. For this reason, even though they were not chosen to
represent a demographic group, they may have been characteristic of others who shared
their demographics. The homogeneity of the group also insured validity. Saturation was
achieved before the 20 interviews were completed. The interviewers included two
bicultural, bilingual Latinas and one breast cancer researcher who were present for the
interviews and case review. The knowledge and experience of the three allowed them to
confirm the credibility of the data.
The interviews were long and detailed, with probes for accuracy. This method
provided the assurance of credibility. Demographic data were used to obtain factual
information to triangulate with qualitative data and to check interpretations. Interviewer
bias was addressed by using two interviewers who would review the case findings. In
addition, the biases of the individual interviewers were identified and put aside, or
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“bracketed.” Interviewing was continued until the data became “saturated,” that is, until
the themes were repeated (Lincoln & Guba, 1985).
Data Analysis
The study was designed to comprehend cultural influences by obtaining narratives
focused on an illness experience. The narrative resulted in thick description of a series of
events in the words of the respondents (What happened after you were diagnosed with
breast cancer?). Because all participants in the sample were Latino breast cancer patients,
themes from an emic perspective could be identified as cultural when they were linked to
an etic perspective by the researcher by comparison with existing knowledge. For
instance, there is a large amount of literature describing the views and decision-making
behaviors of breast cancer patients in the general, non-Latino culture in the United States.
Themes that were unique to this group of Latinas could be assumed to derive from the
group context or culture.
Data transformation consisted of three processes described by Woolcott (1994) as
description, analysis, and interpretation. The researcher used NVIVO, an advanced
qualitative analysis software program that aids researchers in handling, coding, and
analyzing large quantities of data (QSR International, 2005). It allowed for initial open
coding, coding into themes, and selective categories of themes. This ensured the
integration of information at different levels of analysis.
According to Wolcott, (1994) the process of description addresses the question,
“What is going on here?” (p. 12). By reading the narratives, the researcher, from an etic
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perspective, perused the data until she comprehended the answer to that question from an
emic perspective. In other words, the data instructed the researcher about what was going
on from the perspective of the patients, using the patients’ own language, and displaying
their reasoning and assumptions. The researcher then began a process that Morse (1994)
defined as synthesizing, that is merging several stories to describe typical patterns or an
average story and sifting, a process of shaking off the insignificant material.
The process of analysis (i.e., making sense of it) involved highlighting
commonalities and patterns, identifying and sorting themes, and contextualizing
(Woolcott, 1994). Stated values and norms were identified in the stories. Next, linkages
were made between emic and etic perspectives by comparing and contrasting cultural
values and norms from the data with existing literature, established theory, or other
cultural groups. According to Woolcott, the process of interpretation involves making
sense of what is going on in a larger context and reaching out beyond scientific data for
understanding. In this focused ethnography, interpretation was used to make
recommendations to improve practice and make suggestions for further research. It also
was used to suggest application to other settings and populations.
Summary
The methods used in this study were chosen as the most effective for answering
the primary and secondary research questions. Because culture is key to answering the
research questions, culture theory and focused ethnography were used to analyze the data.
Using established qualitative analysis methods, efforts were made to assure the reliability
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and validity of the results. Chapter 4 contains a discussion of the analysis and the results,
and chapter 5 interprets the results and offers recommendations.

CHAPTER 4: RESULTS
Processing the Archived Data
The process of generating, gathering, and recording the archived data was
discussed in chapter 3. In-depth interviews were audio-recorded by two interviewers with
the respondent’s permission. These recordings were then transcribed and translated by a
transcription service. The transcriptions were reviewed by the original bilingual
interviewers, who listened to the original recordings, when necessary. Electronic files of
the transcriptions were entered into NVIVO software for processing. The interviews,
which were from 90 to 180 minutes long, resulted in a massive amount of data. QSR
(2005) NVIVO was used to manage the data and to aid in handling, coding, and
analyzing them. The program allowed for initial open coding, thematic coding, and
selective categories of themes. This management tool allowed the researcher to integrate
information at different levels of analysis. The program also has the capacity to record
demographic and other data as quantitative data to be used to sort cases by various
attributes such as age or country of origin. This tool made it possible to display
demographic details of the sample.
First, the data underwent open coding, a process that allowed the researcher to
identify small chunks of data and to code them. For instance, when the subject of the
patient’s children was raised in any context, the section of text was coded as Children.
These code names were saved, and the entire data set was reviewed to identify other
passages that should be coded Children. In open coding, the context is not considered.
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For example, a discussion of “wanting to have children” and a discussion of “getting
support from children” would both be coded Children.
Open codes were allowed to overlap. For instance, “getting support from
children” might have been coded “children,” but it also might have been coded as
Support. The open coding phase identified 56 codes. These codes were then grouped into
categories, or trees. Each tree had subcategories, and each subcategory had coded
passages. These categories were developed by the researcher and were informed by
perusing the entire data set. A list of codes is shown in Appendix B.
Data Analysis
Comprehension and Description
The first step in the analysis was a thorough reading of all transcripts to answer
the question, “What is going on here?” By reading the narratives, the researcher perused
the data until she understood the answer to the question from the perspective of the
patient. In other words, by reading the data from the patient’s perspective and wording,
she began to understand the patient’s reasoning and assumptions.
Synthesis
Handwritten notes were taken by the researcher as she read the transcripts. These
notes were later used to synthesize the stories into typical patterns and stories. The
software also was used at this stage as themes or typical patterns were suggested by
perusing the open codes in a category. For instance, “cause of cancer” contained eight
open codes and one of them, “punishment from God” appeared in six passages.
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Analysis
Analysis can be described as making sense of it. It involved identifying
commonalities and patterns by sorting themes and contextualizing. Typical stories
revealed the stated values and norms of the patients. To move to an etic perspective and
to identify cultural values contained in these narratives, the researcher compared and
contrasted cultural values and norms from the data with existing literature, established
theory, or other cultural groups. For instance, “punishment from God” fit established
theory of Latin American cultural values and perspectives concerning illness and disease.
Interpretation
Interpretation followed the presentation of results. It involved seeing the issues in
the context of literature from the general U.S. population. Grounding the findings in other
literature and identifying cultural influences led to greater understanding of Latino values
that affect behavior.
Evidence of Quality
Several steps were taken to ensure data quality. First, the interviewing team
reviewed all the translated transcripts. Two researchers performed the initial coding
separately, after which they discussed the codes and agreed upon differences. Most often,
differences were in the size of the passage, not in the code, itself. The researcher decided
on categories after reading all the transcripts and reviewing codes. The frequency of
codes was examined and compared to patterns perceived by the researcher. These
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categories, as well as the resulting interpretation, were reviewed by the original bicultural
interviewing team who were present for the interviews.
Results
As shown in the demographics in Table 1, the median age group of the sample
was 40 to 49. Most women were from Central or South America. Of the 20 participants,
12 spoke little or no English. Eighteen of the 20 were employed when diagnosed, many
as housekeepers. Ten women had to leave their jobs when they became ill. Many of the
women had few family members in the United States and relied on their husbands or
parents from Central America for care giving. Because most of the women had children,
husbands had the multiple roles of caregiver, childcare provider, and wage earner.

Table 1
Demographics of the Study Sample

ID

Age

Marital
status

Children

Years
in US

English

Education

Work
before

Work
after

1

50-59

M

2-4

4-5

None

Yes

No

2

60+

S

1

> 20

Fair

Some
HS
Some HS

Yes

Yes

3

30-39

S

1

Little

Yes

NR

4

50-59

S

No

4-5
years
11-20
years

No

NA

5

40-49

M

2-4

6-10
years

None

Some HS

Yes

No

Patient has a husband and two daughters and one boy. Her mother-in-law came from El Salvador
for one month for surgery. Patient’s oldest daughter is her interpreter. Her husband has to work –
“money is an issue with three children.” No other family.

6

60+

W

1

6-10
years

None

Grade
school

Yes

No

Patient has a friend who helps her. She lives with her brother who is no help. Patient lost her
housekeeper job. There is no other family in the area.

7

40-49

M

2-4

11-20

Little

Yes

Yes

8

40-49

M

2-4

4-5

Fair

Some
HS
College

Yes

No

9

40-49

M

2-4

11-20

None

Yes

No

10

50-59

Sep

2-4

1-3

Little

Yes

No

11

50-59

S

2-4

6-10

Fair

Grade
school
Some
HS
Some HS

Yes

No

12

50-59

M

2-4

<1

Little

Some HS

No

No

Patient has a husband but no other family in the area. Both work – at a restaurant and cleaning.
They send money to their children in El Salvador.
Patient has an American friend who helps her, since patient’s husband is a truck driver. There is no
other family.
The patient’s husband works as a cleaner at a hospital. They have two young children and no other
family.
Patient lives with her two teenagers. She has an aunt and uncle in the area but only her uncle
speaks English.
Patient has a daughter who is 20 years old and has a small child. The daughter works to support
them. There is no other family
Patient has a son but no other family. Her son translates. She is separated from her husband.

13

50-59

S

1

> 20

Fair

Yes

No

14

30-39

S

2-4

1-3

Little

Grade
school
NR

Yes

Yes

15

30-39

M

2-4

11-20

Fluent

College

Yes

No

Little

Some
college
Some
college

Family context

Patient has a husband, son, and daughter. The daughter translates. The husband is a caretaker at a
church. No other family
Patient has a sister, brother, daughter and large family nearby.
Patient has no primary caregiver. She lives with her brother and his wife who don’t take care of her
and demand rent. No other family
Mother and patient went to live at her sister’s house after her diagnosis. Patient’s mother wasn’t
told patient has cancer. There is no other family in the area.

Patient gets help from two friends. She has a son who lives near by but she didn’t tell him about
her cancer. There is no other family.
Patient has no other family in the area. Her mother is visiting from Peru to be her caregiver. Her
mother doesn’t speak English and is worried about husband who is ill in Peru.
The patient’s husband is American. They live together with two children.
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16

50-59

S

No

11-20

Fluent

College

Yes

No

Husband’s mother lives with the couple.

17

40-49

M

1

<1

Fluent

College

Yes

No

Husband visited from Ecuador for her surgery then left. Patient is staying with a friend.

18

40-49

M

No

<1

Fair

Technical
training

Yes

No

Husband is in a wheelchair. Landlady helps the couple. No other family.

19

30-39

M

2-4

11-20

Little

Grade
school

Yes

Yes

Husband is the primary caregiver. He does construction and can’t take off work. They have two young
children and there is no other family in the area. The patient’s mother and father took turns visiting from El
Salvador.

20

30-39

M

2-4

11-20

None

Grade
school

Yes

Yes

Patient lives with her mother, husband and three children. There is no other family in the area. She had
support from her church
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Themes
The following sections show the themes as they were organized to answer the
research question, “What are the cultural beliefs, values and norms that influence Latinas
in choosing to have recommended chemotherapy?” and the subquestions, “What are the
cultural beliefs about disease and illness and about cancer?” and “What are the cultural
values and norms that may play a role in medical decisions?” Although the themes
overlapped, they were organized for clarity into the following overall groups: (a) RoleRelated Themes, (b) Employment/Immigration Status, (c) Beliefs and Knowledge of
Disease and Treatment, and (d) Information and Communication. The themes synthesized
from the data are presented with representative quotations. Next, they are compared and
contrasted with existing literature to identify them as cultural themes.
Role-Related Themes
Social support. Latinos in this sample relied exclusively on extended family for
assistance and support, both social and instrumental. However, as shown in the column
labeled “Family Context” in Table 1, the immigrant status of the females who were
interviewed left them without either extended family or support. The women expressed
feelings of vulnerability because of the lack of nearby family and the reality of being in a
foreign country. Very few of the couples had extended family in the area. For most of the
women, their husbands were their only support, but most of those husbands were
employed in one or more low-paying, hourly jobs in cleaning or construction, so they
could not take time off work. This lack of support was a barrier to treatment for some of
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the women. Also, because many of the couples had limited English, their children often
were their translators, limiting communication with doctors. One woman explained:
It was not easy. And it is not easy now. If this illness had affected me 10-15 years
from now, maybe I could accept it, but I was not here in this country for long. We
do not have family, we do not have anyone. My children never have been with
their father because he has other responsibilities and he does not care too much. It
is hard to live in the US because I am not with my family. [She cried]
The sense of “not having anyone” was exacerbated by reliance on family as the only
source of assistance. Almost none of the women had friends or other contacts outside the
family who helped them.
One barrier to follow-up treatment was a need for social support, both
instrumental and emotional. In the Latinos, a lack of social support was directly related to
the absence of family members. The Latino reliance on family made it less likely that the
women would ask neighbors for help, for instance. Another factor in this reliance on
family was a value of secrecy about cancer.
Gender roles. The women in the sample adhered to the traditional female gender
roles of mother and wife. With few outside resources and a cultural tradition of little male
involvement in child care, the mothers felt they alone are responsible for their children’s
care. The women reported feeling an obligation to provide for their children and their
extended families. One woman was the sole support for her children. She said, “In my
country, people don’t want to spend money to go see a doctor because this money could
be used to feed their children or family. They don’t have (a source of income).” Speaking
of her children in Central America, she said, “I send them everything from here. I think
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that if something happened to me, what would be[come] of them? They don’t know how
to take care of themselves.”
Child care. Traditional, strict gender roles can be a barrier to treatment. Latin
women in general take full responsibility for the well-being of their families; self-care is
a lower priority. Because the responsibility for children and home is not usually shared
with men, there is discomfort when a woman is unable to perform her usual duties. One
woman feared that she would not be able to take care of the children. She said:
I mean you probably are going to feel tired, you are going to have fatigue, you
are going to have nausea. So you won’t be able to keep going with your life as
usual. I know my husband can take care of himself, but I don’t know about my
children. Sometimes you feel indispensable. I thought that if something happened
to me there would nobody who could do these things with them. Who would go
over their homework, would feed, would console them at home. Men don’t do.
My husband is great and everything, but he would not [do] that. Who would talk
to them; give them affection, a hug? That was the hardest thing.
Sexuality and body image. Sexuality and body image were minor themes in our
interviews, mentioned much less than economic, communication, and childcare issues.
Hair loss, however, was mentioned often. One woman commented, “I felt I wanted to die.
I did not want to get it [chemo].” She was asked if it was because she was afraid. She
replied, “Because of my hair. Because the Latinos notice these things more that the
people from this country.” Another woman said:
I think that one of the reasons why Latina women don’t go for treatment is a
cultural issue. Chemotherapy evidently affects your sexual lifestyle. That means
that in a period you are not going to have sexual relations or you won’t feel like
you want it, and that’s always going to disturb in your family life.
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Yet another woman said, “I may not be useful for a man as a woman with no hair,
eyebrows, eye lashes and I may not lead a marital life.” Several women expressed the
fear of losing their husbands during their treatment.
Childbearing. Younger women in the sample expressed concern about being able
to bear children after treatment. They had some conflicting and confused information on
that topic. “In talking to a lot of Latinas, some women that I talk to they think that they
won’t have their family, they wouldn’t be able to have kids after chemotherapy.” When
the interviewer asked another woman, “Did he (the doctor) tell you could have a baby?”
She answered, “The doctor told me that I had to control myself. There were no
guarantees.”
Latinas who adhere to strict gender roles view self-care as less of a priority, even
when seeking treatment. One woman stated:
As Latino women, we prioritize our husbands, our children, the family, and we
stop caring for ourselves, and we could have a discomfort and wait until it goes
away. We don’t think that us as women could also get sick. When we wake up
and seek treatment is too late. Anxiety is caused by responsibility for children
with no other support.
These traditional, strict gender roles can be a barrier to treatment or a facilitator. For
example, responsibility for children may have been a facilitator to following treatment
recommendations when the woman believed that chemotherapy would help her live
longer. One participant commented:
Surely, at the fourth round, I said I did not want to do it anymore. I did not want
it, I did not want have anything to do with it. But my daughter gave me courage.
She told me I had a son I had to fight for, that I had to live because I was needed.
So I did one more and finished the chemotherapy.
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Employment/Immigration Status
The SES of the poor and newly immigrated women in the study sample included
complicated interactions of poverty, job insecurity, lack of health insurance, low
education, and language barriers. One woman said her first thought was, “How am I
going to go to treatment if it is not cheap?”
Apart from treatment costs and the lack of health insurance, important issues
related to the often precarious economic situations of the women and their families
affected chemotherapy decisions. Most of the women were employed at the time of their
diagnosis, whether married or single, and their incomes were needed by the extended
families here and in their native country for subsistence. Most of the women and their
husbands were employed in unskilled, low-paying hourly labor such as housecleaning
and construction, which provided no compensation for sick leave or personal leave. If the
woman could not work because of treatment, her salary would be lost; if her husband was
needed to provide child care, transportation, or other assistance to her, his salary also
might be lost.
In addition, the jobs often were not secure. The participants feared losing their
jobs if they took too much time off. This was an issue for the women as well as for the
husbands/caregivers. As one woman said, “It’s difficult to get time off from work. There
are always problems with the bosses. Even if you have insurance and everything, there’s
a problem because nobody wants to miss work.”
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The cultural norm of respeto, unique to Latino immigrants, interacted with these
work realities. For example, some women were hesitant to discuss their illness with
employers (superiors) or to request special treatment. One woman said:
Since one always thinks about eating. That’s why you have to work because you
don’t have kids, nothing. I asked my boss for permission to come in earlier and
leave earlier too. I told him I was receiving some therapy. He never knew. The
other work mates asked what was happening with me. They thought I was being
favored, but to date, they don’t know anything.
Many women reported keeping their treatment secret from employers. One woman
expressed these conflicting pressures as too difficult to manage. She said, “Sometimes
you don’t want to not go to work. Sometimes you want to die instead of getting
treatment.”
Insurance. The women in the sample who had no insurance were eventually able
to receive treatment from governmental and charitable sources. However, many of the
participants said that most women do not know about these resources. Some women
expressed concern about using these resources, and others felt that they were not entitled
to get a second opinion or to ask questions because they were accepting help. One
participant stated:
He (the doctor) told me surgery and chemotherapy, but I would have liked to
consult with another doctor if I had known how to speak English. I also was
blinded and said to myself that if the doctor said that I needed the mastectomy
then he should do it once and for all. I did not check with other doctors.
Beliefs and Knowledge of Disease and Treatment
The women expressed the view that Latinas from their countries do not know
anything about chemotherapy. They said that most people have not heard the word and
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that those who have heard the word do not know what it means. They acknowledged that
they also had not known anything about chemotherapy before they had cancer. They
presented several reasons for this lack of knowledge. First, there is a cultural norm of
secrecy about cancer that extends to cancer treatment. Also, as one woman noted, when
poor people in their countries get sick and die, they often have had no medical treatment,
so chemotherapy is never discussed. Sometimes, the knowledge that the women gained
from experience or from others was incorrect. Several women spoke of their fear of
information and general avoidance of anything concerning health and treatment (e.g.,
“Illness, no, it’s over there”).
Some of the women who had heard of chemotherapy had many misconceptions
about it. Most relevant was the belief that chemotherapy is not effective. Table 2 is a
summary of the participants’ narrative comments about chemotherapy. It is presented in
table format to highlight the degree of misunderstanding.
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Table 2
Perceptions of Chemotherapy
“There were some masks which I thought were used in chemo. I thought they would make the
women wear the masks.”
“I knew that in many cases it would not work. That’s what I knew. But I did not know about
how the treatment was. I was never interested in obtaining information. There are people that
get informed about it, but I was so afraid that …..(I didn’t want to learn).”
“What I hear people say chemotherapy does is that it damages the body.”
“I thought that cancer meant death and that chemo also meant death.”
“I thought that with the chemo, they would pass you through a machine. Many people thought
that too. Nobody had that information about chemotherapy.”
“I heard that when you die you die, but chemotherapy helps. My friend mentioned that even
when you receive the chemotherapy, you still die.”
“I only heard it (chemo) from a neighbor. It’s not in open conversation. I don’t know if it’s
because of the fear or if it does not exist (in country of origin).”
They told me that I would first need to go to a doctor, an oncologist, to see if I needed
chemotherapy. When they told me this, I think that this was the biggest fear and blow that I
had, bigger then knowing I had cancer. Because my grandmother, on my mother’s side also
died of cancer and I saw her suffer for a year. This was terrible. She suffered a
lot. And we were all with her the whole time, so Oh! When they told me chemotherapy, I
said, “Oh, my God!” I said that I did not want this, I won’t do it.
Many women said that their expectation before treatment was that chemotherapy was “very
painful.” They learned about the side effects of hair loss, nausea, fatigue, and other symptoms
either immediately before or during treatment.
I did not know the significance of chemotherapy because I had never heard that word. Cancer
yes, because I had experience with my mother, but 35 years ago. I thought that they would be
giving me ultraviolet or radio laser, and put a liquid-ultraviolet to hold the cancer, since this is
what they did to my mother. This was the concept that I had of breast cancer.
If they told you [that] you have cancer and then they give you chemotherapy, which is going
to make you lose your hair, she said. She also said, “I was not going to be able to care for
myself. That I would need somebody to help me like a handicapped person.”

Because these responses were so discrepant from those of other breast cancer patients in
the United States, they highlighted the lack of experience and education that results in
misconceptions about the barriers to chemotherapy use.
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Information and Communication About Chemotherapy
The timing of information about treatment was not optimal to decision making in
the women who had many misconceptions about chemotherapy. Most of the women who
were interviewed received little or no information about chemotherapy before their first
treatment. Only at the time of treatment were they given information about potential side
effects. The women who spoke English; were educated; and had someone else to help
them obtain information (e.g., a patient navigator, support group, educated relative) had
enough information to make an informed decision before treatment. Of note, very few of
the women were given information about the benefit of chemotherapy. For those women
who believed that chemotherapy often does not work and harms the body, this
information was crucial and could have facilitated the decision to use chemotherapy. One
woman commented:
He (the doctor) told me that he had to give me chemotherapy and radiation
treatment and all of that. I was ignorant about all of that because I had never heard
talked about chemotherapy or radiation. I did not know what I was going for.
From knowing that they were going to do the first chemotherapy, I was
scared of the medicine and I had a lot of questions. Everybody spoke English. At
the moment when you’re having tension you can’t emit words and ask questions
even though you have the interpreter in front of you. And what about survival?
Did the doctor tell you anything about that? The lifespan you had? No, we did not
talk about that. Did you ask? No, because my oncologists did not speak Spanish.
And at that clinic nobody speaks Spanish.
I, from the first moment, did not want chemotherapy. I accepted
chemotherapy, Why? Because I ask a lot of questions, because I have the will to
know more, but not everybody are predisposed like me and a lot of people,
because I even heard people did not want to know it during the consultations with
the doctor at Nueva Vida. They get stuff (written material), they give them the
appointment and everything and the people say no. Why? Because it is a lack of
information I think, no? Ignorance of not knowing exactly what chemotherapy is
really for.
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I think there are a lot of factors (why a woman wouldn’t want treatment):
first the fear of what chemotherapy is; what reaction will produce; what will
cause; how my life will be from now on; what will happen.
Most of the women who were interviewed revealed that they were not
comfortable asking their doctors any questions. This discomfort was related to language,
education, lack of health insurance, and a reticence to communicate with their doctors.
The women described it as follows:
I only cried. I did not ask. I don’t ask questions. I take my friend to make the
questions. I have fears of asking questions. (Doctor) told me that I spoke English
and how come I don’t ask questions. I would let her ask the questions and then
she would tell me to take the pill everyday at the same time and that I will be ok. I
don’t like to ask questions. I get there and I don’t know what to do.
The language factor prevents us from expressing what we want to say. If
you ask, they (the doctors) will answer, but if you want to ask and you don’t know
how then ….. I asked a few things and I understand better when they talk to me
than me talking. That was my problem in my case. But in fact I did not understand
the importance of chemotherapy in the body. I could not talk to (the doctor)
directly. I had interpreters.
Avoidance. Another barrier to communication that was shared by many of the
participants was a preference for little information. Some patients spoke of not wanting
information because it made them anxious. For instance, as an example, 1 patient said
that after her diagnosis in a physician’s office, she did not want to go anywhere else. “No,
I did not want to go anywhere.” They had information in the doctor’s office, but she said,
“Yes, they have books in Spanish, but I was not interested in reading them. So I never
had any.”
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Interactions with doctors. Doctors were the most powerful force for information
and communication. Written materials were not helpful, and the women often did not
discuss their cancer with others. One woman said:
I accepted the treatment. I accepted because it came from the mouth of the doctor
because she said that this was what could save me. But I did not investigate; I did
not have any chance to investigate. I did not have the opportunity to talk to other
doctors. I would have liked to have a doctor that spoke Spanish, to ask questions,
to be satisfied. Here the only thing I can do is accept, because we were going
against time. I did not know anyone with experience. So the only thing left was, I
was on the horse so my only option was to ride it.
There were two exceptions of doctors being successful at communication. The
first doctor was able to communicate despite language problems. The second took the
time to discuss the prognosis in simple, understandable terms. Comments included the
following:
The surgeon was a person that always talked to me. He was kind and was the
greatest medical support even though he did not speak Spanish. Signaling and
gesturing me, he made me understand what he was talking about. He told me
about him, that he had been operated for prostate. He told me, “Look at me, at my
age, I’m old and I still live to take care of grandchildren and to enjoy their
company. So you are going to live many more years. Stick that idea in your
head.” So he was the one that talked to me like that. So I said that if he said so,
then it must be truth. So, it was worth it that I would start the treatment. He
explained it to me. He told me about that. He told me I was going to lose my hair,
that I was going to have vomits and headaches, but that I would overcome them at
the fourth, third day. Things occurred the way he told me. It happened to me. My
hands and nails turned black. He tried to find information in Spanish
unsuccessfully.
They gave me some information in English. That’s why I never read them.
When we went find out about the options, the doctor who did the mastectomy
found out about this oncologist who was going to make the decisions. He put in
the computer that if I did not get the chemos, I’d have 70% chances of having the
cancer grow back, and a 30% of not having it grow back. If I got the chemo, these
numbers would be the other way around. So 70% would mean that the cancer
does not grow back, but he does not guarantee that this may not grow back. So, I
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will always have a big percentage of chances that this grows, and it could grow
anywhere, not only in the breast.
Interpretation
The themes that emerged from the interviews can be compared to existing
literature about cancer treatment in women. When compared to existing literature about
Latinas and cancer, the similarities suggested that the themes were consistent with
recognized Latino values. When compared and contrasted with literature about the
general population of (mostly) White breast cancer patients, the contrasts identified
values unique to Latinos. By grounding the findings in other literature and identifying
cultural influences, it became possible to see the issues in a larger context and reach out
beyond the data for understanding. Interpretation allowed the researcher of this focused
ethnography to make recommendations to improve practice in similar settings and
populations.
Role-related themes. Studies of Latino culture have identified the importance of
familisma and collectivism in social support and machismo in strict gender roles.
Because of the value of familisma, Latinos are reliant on family for social support and are
less likely to seek social support outside the family (Alvirez & Bean, 1976; Sabogal,
1987; Campaña, 1989). Gender roles for women include the responsibility for everything
associated with the home, including caring for children, sick family members, and older
relatives (Marin & Marin 1991; Vernon & Roberts, 1985). It also includes the role of
wife: being available sexually, valuing body image, and being able to bear children. In
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summary, role-related themes have been documented in the existing literature about
Latino culture.
In contrast, the U.S. majority population of breast cancer patients have fewer
concerns about fulfilling their roles and more concerns about dealing with symptoms
such as nausea that are affecting their quality of life. Although some patients reported
concerns about how their cancer will affect their families, this concern was related to
their family members’ psychological stress, not to survival. However, like Latinos, some
breast cancer patients from the majority population have general financial concerns
(Lindley et al., 1999).
Employment/Immigration status. The women who were interviewed were
concerned not only with fulfilling traditional roles but also for earning a living and, often,
for sending money to relatives in their home countries. Thus, problems of poverty,
financial insecurity, and immigration status interacted with traditional values. For
instance, financial insecurity added to Latino values of respeto (power distance:
respecting those in authority) and secrecy about cancer, so a Latina breast cancer patient
did not inform her employer of her illness. Likewise, the combination of respeto and a
lack of health insurance made the women afraid to question their doctors about their
cancer treatment. The women in this sample did not have private insurance, but they did
have medical care for their cancer from a variety of sources. However, what was
perceived as charity made them less empowered to question authority.
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Immigration status also had several effects on the women’s lives. First, they often
were isolated and without extended family. Next, it was more difficult for family
members to travel to care for them. The literature has documented Latinos’ lack of
knowledge about cancer and treatment (Perez-Stable et al., 1992). There are several
reasons Latinos misconceive the cause and course of cancer and the benefits and side
effects of treatment: They are likely to come from countries with a cultural norm of
secrecy about cancer, late diagnosis (higher morbidity and mortality), and inadequate
treatment for pain and other symptoms.
In the sample interviewed by this researcher, the women’s fears and
misconceptions were striking. In addition, none of the women reported that a doctor or a
nurse provided specific information about the process until she arrived for the first
treatment, after having made a decision.
In the general U.S. population, several studies have shown that patients’
expectations of chemotherapy side effects are significantly worse than their actual
experience with chemotherapy, that is, once they have had it. This difference is
increasing as progress is made to make chemotherapy less toxic with decreased side
effects and patients’ expectations are staying the same (Carelle et al., 2002; Lindley et al.,
1999; Passik, Kirsh, Rosenfeld, McDonald, & Theogold, 2001). However, this researcher
does not know of any study that has questioned women about the process of getting
chemotherapy and radiation. Personal experience, however, has suggested that the
average American woman can be expected to know how radiation and chemotherapy are
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given. Although she may fear the side effects, she does not fear the process of receiving
treatment.
Information and communication. Avoidance of information about medical topics
(bad news) is a value shared by Latinos. This value has been explored in the literature,
especially in cancer and palliative care literature (Blackhall, Frank, Murphy, & Michel,
2001). The belief is that truth is harmful and it is better not to know and to leave things in
the hands of God. This is in contrast to studies in the general U.S. population that have
concurred that most cancer patients want information about their disease and treatment
(Cassileth, Zupkis, Sutton-Smith, & March, 1980; Sutherland, Llewellen-Thomas,
Lockwood, & Trichler, 1989).
Summary
The 20 interviews yielded a large amount of data. To make the data
understandable and useful for practice, it was necessary to process them through several
steps, including coding, categorizing, reading for comprehension, synthesizing, and
comparing the results to existing literature. This process resulted in a rich description of
how 20 Latinas with breast cancer made sense of their illness and treatment. It also
described how their beliefs and preferences, acting in the context of their lives, may have
influenced their decisions about follow-up treatment such as chemotherapy. The
following chapter includes an interpretation of the results, the significance of the results,
and implications for practice.

CHAPTER 5: SUMMARY, CONCLUSION, AND RECOMMENDATIONS
Overview
Breast cancer is the leading cause of death in Latino females. In the Washington,
DC, area, Latinas, as well as other females of color, are twice as likely as White females
to die of diagnosed breast cancer. Although most research has focused on disparities in
early detection, there is evidence that there are disparities in follow-up care and that
Latinas are less likely to receive optimal follow-up treatments such as chemotherapy after
they have been diagnosed and received surgery. There is additional evidence that there
are cultural reasons for treatment disparities not attributable to insurance status and
access to care.
The purpose of the study was to explore the reasons Latino females may be less
likely to receive follow-up treatment for breast cancer. The objective of the study was to
examine relevant cultural factors by analyzing in-depth interview data from 20 Latina
breast cancer survivors for whom insurance may have been an issue, but access to
medical care was not an issue. A deeper understanding of the phenomenon was sought in
order to inform future efforts to improve care and reduce mortality.
The specific research question asked, “What are the cultural beliefs, values and
norms that influence Latinas in choosing to have recommended chemotherapy?”
Subquestions also were raised: “What are the Latino cultural beliefs about disease and
illness and about cancer?” and “What are the Latino cultural values and norms that may
play a role in medical decisions?”
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Using the overall framework of culture theory and the method of focused
ethnography, the data were analyzed and interpreted to explain how culture may
influence Latina breast cancer patients to underuse recommended chemotherapy. An
emphasis on culture required a comparison of key themes with other cultural groups and
existing literature about Latinos. The results of the analysis confirmed the influence of
culture on the health decisions and behavior of Latino breast cancer patients.
Summary of the Findings
Culture-specific factors such as strict gender roles; avoidance; respeto (i.e., the
tendency not to challenge authority figures); familisma (i.e., not asking for help outside
the family); and secrecy about disease (fear and shame about cancer) were found to be
influential. In addition, demographic factors, including immigrant and employment
status, were influential, especially when combined with cultural values. For instance, the
need to support children by working two jobs can add to a tendency to secrecy and
avoidance so the breast cancer patient does not follow through with treatment. Social
support, traditionally supplied by family members, often was missing in this immigrant
group. Because the women were very concerned with fulfilling the strict gender roles of
wife and mother, the issues of body image, sexuality, childbearing and childrearing were
primary concerns. The researcher also found pervasive gaps in knowledge and access to
information in this sample, a gap which often supported mistaken beliefs.
Communication with physicians was less than optimal for many of the women
because of language barriers, a cultural reticence to ask questions, and feelings of
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disempowerment because of a lack of insurance. An important finding relevant to
decision making was that the women had exaggerated fears of chemotherapy and
undervalued its benefits, even after communicating with doctors and nurses. Information
about its side effects and the process of chemotherapy often was given too late. Written
information, even in Spanish, was not helpful.
Interpretation of the Findings
Previous studies have found that both cultural norms and immigrant status are
influential in the health behaviors of Latinos (Alferi et al., 2001; Borrayo & Jenkins,
2003; Campaña, 1989). The results from this study highlighted the barriers created for
Latino immigrants who have little local family support and cultural norms of familisma
and strict gender roles. Although many interventions focus on the barrier of insurance
status, the results indicated additional barriers created by a lack of caregiver support and
the need to continue working.
Other studies have reported that Latinas’ beliefs about cancer are different from
those of White women and that those perceptions and beliefs play a significant role in
their health behavior (Facione & Giancarlo, 1998; Hubbell et al., 1996). Latinos fear
cancer more than any other disease, and the shame and secrecy about cancer foster
mistaken beliefs (Hubbell et al.). In addition, Latinos are less convinced than Blacks and
Whites about the effectiveness of cancer treatment. However, they are very concerned
about the side effects from cancer treatment and are more fatalistic than other groups
(Perez-Stable et al., 1994). The results confirmed these findings and showed the extent
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and nature of misconceptions about chemotherapy. These results indicated that
information will be more useful if patients’ misconceptions are addressed immediately.
Communication is an important moderator to barriers created by SES influences
and beliefs. In Latino cultures, there is a tendency for physicians and family members to
withhold information about cancer from the patients, including prognosis (Blackhall,
Murphy, Frank, Michel, & Azen, 1995). There also is a reluctance of patients to ask
questions and challenge authority figures (Marin & Marin, 1991). These barriers exist in
a population in which communication is needed to turn misperceptions and fear into good
decisions. Good communication includes Spanish-speaking providers or good translation
(not using children), providers who understand existing perceptions and beliefs, an
understanding of Latinas’ communication style, and an understanding of the power of
physicians in the dyad. Ideally, the doctors would know the women’s family status and
responsibilities and the pressures on them to continue to function.
Implications for Social Change
This study was the first study that this researcher knows of its kind with this
population. It may lead to interventions to change beliefs and perceptions of adjuvant
therapy, especially chemotherapy, following breast cancer. The results may be used by
clinicians in their practices to improve their communication with Latina patients and by
other groups to provide educational and counseling interventions. These results also may
inform researchers about cultural influences on the decision to accept chemotherapy as a
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treatment for other cancers, especially other female cancers. The findings also may be
used by other researchers to explore health behaviors for other diseases.
Disparities in cancer mortality are a public health concern. A woman of color in
Washington, DC, is twice as likely as a White female to die of breast cancer. Efforts to
reach the Latino community have too often involved simply translating English materials
into Spanish without understanding how Latino cultures make sense of illness and
treatment, the health literacy level of the audience, and other barriers. Health
communication efforts will not be successful without a deeper understanding of the target
audience. Positive social change is necessary to reduce cancer mortality among Latinas.
Researcher’s Experience
As a breast cancer survivor, I had radiation 5 days a week for 5 weeks. At the
time, I was working at home as a consultant with a flexible schedule. Every day at 5 p.m.,
when it was the least busy, I would drive 5 minutes to the hospital, enjoy a cup of
gourmet coffee, have my radiation, and leave in less than 20 minutes. One day as I was
waiting for my treatment, I began talking with another patient who was Latina. She told
me that she was employed as a housekeeper in another suburb. She had to take two buses
to reach the hospital, so the daily routine took her 2.5 hours. When she got home, she had
children to feed and care for. She was afraid of losing her job because she had to leave
early. She told me that she was so exhausted, she was thinking of stopping treatment. She
also said that if her doctor recommended chemotherapy, she probably would not have it
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because if she had it, she could not take care of her children and “it doesn’t do that much
good anyhow.”
This meeting made me realize that what might seem like an irrational choice to
forego chemotherapy, when seen through my eyes, made more sense when see through
the eyes of this woman. I knew that in the Washington, DC, area, women of color are
twice as likely as White women to die of breast cancer. I also knew that although the
focus has been put on late diagnosis, this is not the whole story. Black women and
Latinas were not getting the follow-up treatment that would keep them alive.
In order to improve cancer care, as part of the Latino Cancer Care Consortium
(LACRC), two colleagues and I had the opportunity to talk with 20 Latina breast cancer
patients about everything that happened following their diagnosis. They all had access to
medical care, although most were poor. As I listened to the interviews, I heard beliefs and
values that did not occur in the majority population. It occurred to me that a systematic
and thorough analysis of these data might reveal cultural and contextual reasons Latinas
may choose or reject follow-up treatment for breast cancer. An understanding of these
reasons and insight into the culture might help healthcare educators and providers to
support Latino patients in making such important medical decisions.
My experience as a patient, training as a researcher, and opportunity through the
LACRC made me enthusiastic about this exploration. As someone from outside the
Latino culture, I could conduct the analysis from an etic perspective. As a cancer patient
and researcher, I had an insider’s understanding of the concerns of non-Latina breast
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cancer patients with which to compare. As an outsider, during the study, I learned to
move beyond stereotypes. For instance, I asked a lot of questions about spirituality,
expecting it to be an important factor. Instead, unexpected themes emerged, for instance,
the importance of secrecy about cancer and job insecurity. As I proceeded to analyze the
data, I was shocked to find out the misperceptions about the process of getting
chemotherapy and about the extent to which Latinas underestimate chemotherapy’s
benefits. If I had attempted to educate the woman I spoke with about chemotherapy, I
would have missed her possible fear of what she perceived as the unknown horror of
getting chemotherapy. I might also have missed her reluctance to ask questions or to
share her beliefs.
Recommendations
Informed by this study, I would make the following recommendations regarding
the provision of education and decision support to women following breast cancer
surgery:
1.

Written material, even in Spanish, is not helpful for most Latinas. If it is
used, it should be developed for the population. It should not be a
translation of English materials.

2.

Because Latinas may not know the process of getting chemotherapy,
physicians, nurses, or navigators should take the newly diagnosed patients
on a tour of the chemotherapy site and allow them to see the facility and
equipment and speak with the chemotherapy nurses.
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3.

Latinas may not know about the side effects of chemotherapy and may
have had negative past experiences or beliefs. Physicians, nurses, and/or
navigators should assume that patients have no knowledge of what to
expect from chemotherapy and may have exaggerated fears.
Conversations to elicit and address patients’ fears should include
discussion of the improvements made to reducing the toxicity of
chemotherapy.

4.

Latinas may not understand the benefits of chemotherapy. Discussions
should include clear and simple explanations of the expected outcome
associated with having or rejecting chemotherapy. This could be
reinforced with simple diagrams.

5.

Latinas may be afraid of asking questions. Time should be spent
encouraging questions through all phases of any discussions. Bicultural
navigators are very helpful. Another approach is to suggest questions that
other women have asked and to answer them.

6.

Latinas are less likely, given their culture of defining health as feeling
well, to understand the logic of treating a “disease,” if they feel well, with
a treatment that creates “illness.” This difference should be addressed. A
woman may be feeling well, so she may not think that she needs
treatment.
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7.

Latinas are very concerned about functioning in their roles as wife,
mother, and employee. They may have job insecurity and financial
responsibilities here and in their birth country. In many areas of the United
States, there are resources to help cancer patients with transportation and
child care. Latinas may not know about these services, so a resource guide
may be helpful. Also, a bicultural navigator could help the women access
services, find a Spanish support group, and, possibly negotiate with their
employers.

In summary, these guidelines, based on the data derived from this study, may be
helpful in any setting where there are cancer patients, especially newly diagnosed patients
before treatment. They should be reviewed by doctors, nurses, social workers, navigators,
or others who see cancer patients. The data indicated that professionals should rely less
on the use of written materials and commit more staff time. They highlighted the
usefulness of patient navigators, especially bicultural patient navigators, decision support
tools, and Spanish support groups.
Dissemination
These results will be submitted as an article to a peer-reviewed journal for cancer
researchers and clinicians. They also will be presented to the LACRC in Washington,
DC, and to the American Cancer Society.

78
Recommendations for Further Study
The results of this study suggested that further study, including other cancers and
other chronic diseases in the Latino population, be undertaken based on these insights
into cultural understandings of illness. The results confirmed the influence of culture on
health behavior in cancer treatment, suggesting the potential for future studies of other
ethnic groups, such as Chinese and Whites.
An important area of further study is the development and testing of interventions
to provide education and decision support for Latinas with breast cancer. Using the
aforementioned guidelines, new materials and approaches could be designed to target
Latinos.
Summary
The most important message from this analysis is that not all patients are the
same. Culture and context matter if the goal is to reduce disparities in mortality rates
from breast cancer. In America’s multicultural society, one cannot rely on a commonality
of understanding, values, and life context for which existing educational materials and
approaches were developed. What is a rational health decision for a woman of one
culture may not be a rational health decision for a woman from a different culture. Not
attempting to understand the thinking of those of different backgrounds will result in the
failure to deliver the best care.
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APPENDIX A: OPEN-ENDED INTERVIEWS
“Please tell me about when you were diagnosed with breast cancer and what happened”
Allow the narrative to continue. 60-90 minutes

Ask the following questions, if not mentioned in the narrative:
What did the doctor say to you when you were diagnosed? What were the pros and
cons of having chemo? What did you think the side effects would be? What were the
most important reasons for you to having chemo and the most important reasons for
you not having chemo? What were your biggest fears and worries?
What about your husband, children, other family, or friends? What did they think?
How did your husband react?
What did you think would be the results of treatment? On survival (how much time
would it add?)? Side effects? Why – where did you get this information?
Do you know anyone else who had chemotherapy? If so, what did you learn from them?
Who did you tell about your cancer? Did you pretty much tell everyone? Why not? How
did you think people would treat you?
What do other people you know think about breast cancer and about chemo? Whom did
you talk to about your decisions? Try to remember as much as possible about your
conversations. What did people tell you either for or against chemotherapy? Who had the
strongest opinions about chemotherapy? What were they?
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What do people you know think chemo does to you or does for you? What do people
from your country think about chemotherapy? What did you think about cancer and
chemo before you had it? How have your family and friends treated you since you’ve had
cancer?
Did you think about why you got cancer? What are the mistaken ideas that people you
know have about chemo?
Why do you think women who have come here from Latin countries might be less likely
to have chemotherapy?

APPENDIX B: LIST OF CODES
Number of Nodes: 151
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46

about diagnosis
admiration
advice from others
attitude
away from home
barriers to chemo
Birth after 30
blow to the breast
body image
careless
cause of cancer
change from illness
childbearing
children
compare origin to US
consumption of chicken
continuous sexual relations
denial
depression
diet
environmental contamination
extended family
fatigue
fear, anxiety
femininity
Gods punishment
hair
husband-partner
infections
Information
knowledge and percepts chemo
knowledge of others cancer-chemo
knowledge-percepts of cancer
language-literacy
money for family
money-insurance
natural medicine
nausea
pain
reaction others
rejection
response to diagnosis
role of mother-wife
secrecy
sex
sexuality
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47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97

skin
smoking
spirituality
stress
support others
time for chemo
tradeoffs
trust of hospital or MDs
wanting death
work
(1) /Feelings
(1 1) /Feelings/attitude
(1 1 1) /Feelings/attitude/about diagnosis
(1 1 2) /Feelings/attitude/admiration
(1 1 3) /Feelings/attitude/advice from others
(1 2) /Feelings/change from illness
(1 2 1) /Feelings/change from illness/away from home
(1 2 2) /Feelings/change from illness/careless
(1 3) /Feelings/denial
(1 4) /Feelings/depression
(1 4 1) /Feelings/depression/spirituality
(1 5) /Feelings/fatigue
(1 6) /Feelings/fear, anxiety
(1 7) /Feelings/Gods punishment
(1 8) /Feelings/husband-partner
(1 9) /Feelings/pain
(1 10) /Feelings/rejection
(1 11) /Feelings/reaction others
(1 12) /Feelings/spirituality
(1 13) /Feelings/stress
(1 14) /Feelings/wanting death
(1 14 1) /Feelings/wanting death/barriers to chemo
(1 15) /Feelings/secrecy
(4) /Gender Role
(4 1) /Gender Role/Birth after 30
(4 2) /Gender Role/body image
(4 3) /Gender Role/childbearing
(4 4) /Gender Role/children
(4 5) /Gender Role/continuous sexual relations
(4 6) /Gender Role/femininity
(4 7) /Gender Role/hair
(4 8) /Gender Role/rejection
(4 9) /Gender Role/role of mother-wife
(4 10) /Gender Role/sex
(4 11) /Gender Role/sexuality
(4 12) /Gender Role/skin
(5) /Employment~Immigration
(5 1) /Employment~Immigration/away from home
(5 2) /Employment~Immigration/compare origin to US
(5 3) /Employment~Immigration/money for family
(5 3 1) /Employment~Immigration/money for family/children
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98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148

(5 4) /Employment~Immigration/money-insurance
(5 4 1) /Employment~Immigration/money-insurance/language-literacy
(5 5) /Employment~Immigration/time for chemo
(5 6) /Employment~Immigration/work
(6) /Communication with Doctors
(6 1) /Communication with Doctors/secrecy
(6 2) /Communication with Doctors/trust of hospital or MDs
(6 3) /Communication with Doctors/Information
(6 4) /Communication with Doctors/knowledge and percepts chemo
(6 5) /Communication with Doctors/knowledge-precepts of cancer
(6 6) /Communication with Doctors/language-literacy
(6 7) /Communication with Doctors/language-literacy 2
(6 8) /Communication with Doctors/tradeoffs
(6 9) /Communication with Doctors/trust of hospital or MDs 2
(7) /Social Support
(7 1) /Social Support/extended family
(7 2) /Social Support/husband-partner
(7 3) /Social Support/reaction others
(7 4) /Social Support/support others
(7 5) /Social Support/extended family 2
(7 6) /Social Support/rejection
(7 7) /Social Support/reaction others 2
(7 8) /Social Support/response to diagnosis
(7 9) /Social Support/secrecy
(7 10) /Social Support/support others 2
(7 11) /Social Support/wanting death
(8) /Knowledge of Cancer~chemo
(8 1) /Knowledge of Cancer~chemo/about diagnosis
(8 2) /Knowledge of Cancer~chemo/barriers to chemo
(8 3) /Knowledge of Cancer~chemo/advice from others
(8 4) /Knowledge of Cancer~chemo/careless
(8 5) /Knowledge of Cancer~chemo/cause of cancer
(8 6) /Knowledge of Cancer~chemo/consumption of chicken
(8 7) /Knowledge of Cancer~chemo/diet
(8 8) /Knowledge of Cancer~chemo/environmental contamination
(8 9) /Knowledge of Cancer~chemo/Gods punishment
(8 10) /Knowledge of Cancer~chemo/hair
(8 11) /Knowledge of Cancer~chemo/infections
(8 12) /Knowledge of Cancer~chemo/Information
(8 13) /Knowledge of Cancer~chemo/knowledge and percepts chemo
(8 14) /Knowledge of Cancer~chemo/knowledge of others cancer-chemo
(8 15) /Knowledge of Cancer~chemo/knowledge-precepts of cancer
(8 16) /Knowledge of Cancer~chemo/natural medicine
(8 17) /Knowledge of Cancer~chemo/response to diagnosis
(8 18) /Knowledge of Cancer~chemo/smoking
(8 19) /Knowledge of Cancer~chemo/tradeoffs
(8 20) /Knowledge of Cancer~chemo/cause of cancer 2
(8 21) /Knowledge of Cancer~chemo/blow to the breast
(8 22) /Knowledge of Cancer~chemo/consumption of chicken 2
(8 23) /Knowledge of Cancer~chemo/denial
(8 24) /Knowledge of Cancer~chemo/depression
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149
150
151

(8 25) /Knowledge of Cancer~chemo/diet 2
(8 26) /Knowledge of Cancer~chemo/environmental contamination 2
(8 27) /Knowledge of Cancer~chemo/fatigue
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